ACVR2A
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00592 | T556 | Sugiyama | PODXL PCLP PCLP1 | DsWIVPLDNLTKDDLDEEEDtHL__________________ |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O95394 | S64 | Sugiyama | PGM3 AGM1 | LLAVLRSKQTKSTIGVMVtAsHNPEEDNGVKLVDPLGEMLA |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S114 | Sugiyama | ALPP PLAP | DRFPYVALSKTYNVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P05198 | T284 | Sugiyama | EIF2S1 EIF2A | EKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVDGDD |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05787 | S477 | Sugiyama | KRT8 CYK8 | SSRAVVVKKIETRDGKLVsEssDVLPK______________ |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08670 | S299 | Sugiyama | VIM | VAAKNLQEAEEWyKSKFADLsEAANRNNDALRQAKQESTEY |
| P09923 | S111 | Sugiyama | ALPI | DRFPYLALSKTYNVDRQVPDsAATATAYLCGVKANFQTIGL |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10696 | S111 | Sugiyama | ALPG ALPPL ALPPL2 | DRFPYVALSKTYSVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | T103 | Sugiyama | PRKCSH G19P1 | KPLyIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKE |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18858 | T183 | Sugiyama | LIG1 | sLTEAEVAtEKEGEDGDQPttPPKPLKTSKAEtPtEsVsEP |
| P18887 | T457 | Sugiyama | XRCC1 | tKPtQAAGPssPQKPPtPEEtKAAsPVLQEDIDIEGVQsEG |
| P21333 | S1459 | Sugiyama | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S1151 | Sugiyama | MAP4 | LSGGGDQREAQtLDsQIQEtsI___________________ |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S70 | Sugiyama | EEF1D EF1D | IARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVE |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P34932 | S414 | Sugiyama | HSPA4 APG2 HSPH2 | ITDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTF |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35269 | S217 | Sugiyama | GTF2F1 RAP74 | RGRRKASELRIHDLEDDLEMssDAsDAsGEEGGRVPKAKKK |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P36871 | S477 | Sugiyama | PGM1 | KQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDG |
| P43121 | T299 | Sugiyama | MCAM MUC18 | PPHFSISKQNPstREAEEEttNDNGVLVLEPARKEHSGRYE |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P49327 | S2198 | Sugiyama | FASN FAS | EVRQLTLRKLQELSSKADEAsELACPtPKEDGLAQQQtQLN |
| P49589 | S305 | Sugiyama | CARS1 CARS | KLVPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKA |
| P49589 | S312 | Sugiyama | CARS1 CARS | GDQKALQEGEGDLsIsADRLsEKRSPNDFALWKASKPGEPS |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50613 | S164 | Sugiyama | CDK7 CAK CAK1 CDKN7 MO15 STK1 | LLDENGVLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELL |
| P50613 | T170 | Sugiyama | CDK7 CAK CAK1 CDKN7 MO15 STK1 | VLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELLFGARMY |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P55081 | T267 | Sugiyama | MFAP1 | ETKKELEENKRsLAALDALNtDDENDEEEyEAWKVRELKRI |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S37 | Sugiyama | YWHAZ | ERyDDMAACMKsVtEQGAELsNEERNLLsVAyKNVVGARRs |
| P63167 | S14 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | _______MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNI |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| Q08J23 | T733 | Sugiyama | NSUN2 SAKI TRM4 | EGVILtNEsAAstGQPDNDVtEGQRAGEPNsPDAEEANsPD |
| Q12906 | T300 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | ASGIVMPDGSGIYDPCEKEAtDAIGHLDRQQREDItQsAQH |
| Q13098 | S468 | Sugiyama | GPS1 COPS1 CSN1 | RRAKAMMLRAAVLRNQIHVKsPPREGsQGELtPANsQsRMs |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15637 | S80 | Sugiyama | SF1 ZFM1 ZNF162 | DLTRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFR |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q92688 | S104 | Sugiyama | ANP32B APRIL PHAPI2 | AEKLPNLTHLNLsGNKLKDIstLEPLKKLECLKsLDLFNCE |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | T1323 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ELGVGQMDWGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMD |
| Q9H0J4 | S1620 | Sugiyama | QRICH2 | GHIYKGRMDTRLPGILRKDSsGTSKRKSQQPRPHVHRPPSL |
| Q9H6Z4 | T363 | Sugiyama | RANBP3 | DANRENAAAEsGsEsssQEAtPEKESLAEsAAAyTKATARK |
| Q9H7D7 | S123 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | SSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLNQT |
| Q9H8H2 | S78 | Sugiyama | DDX31 | LGTSPYSWSRSGPGRGGGAGsSRVPRGVPGPAVCAPGSLLH |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9UI30 | S125 | Sugiyama | TRMT112 AD-001 HSPC152 HSPC170 | RMFPISRGIPNMLLsEEEtEs____________________ |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.192535e-08 | 7.659 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.505376e-07 | 6.822 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.156819e-05 | 4.937 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.118596e-05 | 4.951 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.238759e-05 | 4.205 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 9.742635e-05 | 4.011 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.252923e-04 | 3.902 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.097098e-04 | 3.678 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.372588e-04 | 3.625 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.511553e-04 | 3.600 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.984567e-04 | 3.400 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.837580e-04 | 3.234 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.456945e-04 | 3.263 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.280402e-04 | 3.202 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.340941e-04 | 3.198 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.790794e-04 | 3.056 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.078917e-03 | 2.967 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.355454e-03 | 2.868 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.623009e-03 | 2.790 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.417521e-03 | 2.617 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.501683e-03 | 2.602 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.501683e-03 | 2.602 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.784014e-03 | 2.555 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.857125e-03 | 2.544 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.912534e-03 | 2.536 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.156053e-03 | 2.501 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.392835e-03 | 2.469 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.521945e-03 | 2.453 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.927842e-03 | 2.406 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.958837e-03 | 2.402 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.881117e-03 | 2.411 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.301872e-03 | 2.366 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.378590e-03 | 2.359 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.963180e-03 | 2.304 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 5.573907e-03 | 2.254 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.898330e-03 | 2.229 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.130296e-03 | 2.213 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.334172e-03 | 2.198 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.334172e-03 | 2.198 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.676549e-03 | 2.246 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.074834e-03 | 2.216 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.846418e-03 | 2.233 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.627338e-03 | 2.179 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.008682e-03 | 2.154 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.078778e-03 | 2.150 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.886734e-03 | 2.103 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.886734e-03 | 2.103 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.528233e-03 | 2.123 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.972781e-03 | 2.047 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.564810e-03 | 2.019 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.050171e-02 | 1.979 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.227362e-02 | 1.911 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.319963e-02 | 1.879 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.309971e-02 | 1.883 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.227362e-02 | 1.911 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.267987e-02 | 1.897 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.324188e-02 | 1.878 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.403880e-02 | 1.853 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.411887e-02 | 1.850 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.499489e-02 | 1.824 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.521001e-02 | 1.818 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.545050e-02 | 1.811 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.621096e-02 | 1.790 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.527780e-02 | 1.816 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.598255e-02 | 1.796 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.598255e-02 | 1.796 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.678989e-02 | 1.775 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.746177e-02 | 1.758 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.794817e-02 | 1.746 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.794817e-02 | 1.746 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.868427e-02 | 1.729 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.872473e-02 | 1.728 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.074952e-02 | 1.683 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.074952e-02 | 1.683 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.074952e-02 | 1.683 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.074952e-02 | 1.683 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.074952e-02 | 1.683 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.166226e-02 | 1.664 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.184058e-02 | 1.661 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.331517e-02 | 1.632 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.431489e-02 | 1.614 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.431489e-02 | 1.614 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.425972e-02 | 1.615 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.576627e-02 | 1.589 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.601097e-02 | 1.585 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.667974e-02 | 1.574 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.861796e-02 | 1.543 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.909394e-02 | 1.536 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.555822e-02 | 1.449 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.555822e-02 | 1.449 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.409647e-02 | 1.467 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.409647e-02 | 1.467 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.606139e-02 | 1.443 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.353684e-02 | 1.474 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.353684e-02 | 1.474 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.284335e-02 | 1.484 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.496788e-02 | 1.456 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.128471e-02 | 1.505 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.409647e-02 | 1.467 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.279163e-02 | 1.484 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.606586e-02 | 1.443 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 3.353684e-02 | 1.474 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.027292e-02 | 1.519 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.906845e-02 | 1.408 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.906845e-02 | 1.408 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.906845e-02 | 1.408 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.969237e-02 | 1.401 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.090445e-02 | 1.388 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.122616e-02 | 1.385 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 4.347830e-02 | 1.362 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.347830e-02 | 1.362 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.347830e-02 | 1.362 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.529039e-02 | 1.344 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.691534e-02 | 1.329 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.309691e-02 | 1.366 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.309691e-02 | 1.366 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.269714e-02 | 1.370 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.837983e-02 | 1.315 | 1 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.712399e-02 | 1.243 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.712399e-02 | 1.243 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.893138e-02 | 1.230 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.893138e-02 | 1.230 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.893138e-02 | 1.230 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.893138e-02 | 1.230 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.893138e-02 | 1.230 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.893138e-02 | 1.230 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.018708e-02 | 1.299 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.633094e-02 | 1.249 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.633094e-02 | 1.249 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.285980e-02 | 1.202 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.285980e-02 | 1.202 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.994616e-02 | 1.301 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.994616e-02 | 1.301 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.487269e-02 | 1.261 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.487269e-02 | 1.261 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.973607e-02 | 1.303 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.338672e-02 | 1.273 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.204534e-02 | 1.284 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.821862e-02 | 1.235 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.821862e-02 | 1.235 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.712399e-02 | 1.243 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.712399e-02 | 1.243 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.959442e-02 | 1.225 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.994616e-02 | 1.301 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.093687e-02 | 1.293 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.712399e-02 | 1.243 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.285980e-02 | 1.202 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.633094e-02 | 1.249 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.285980e-02 | 1.202 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.562992e-02 | 1.255 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.031478e-02 | 1.298 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.738683e-02 | 1.241 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.633094e-02 | 1.249 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.516291e-02 | 1.258 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.575096e-02 | 1.254 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.532344e-02 | 1.185 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.553761e-02 | 1.184 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.037641e-01 | 0.984 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.037641e-01 | 0.984 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.037641e-01 | 0.984 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.037641e-01 | 0.984 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.037641e-01 | 0.984 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.037641e-01 | 0.984 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 1.515402e-01 | 0.819 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 1.515402e-01 | 0.819 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.515402e-01 | 0.819 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 1.515402e-01 | 0.819 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 1.515402e-01 | 0.819 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.203271e-02 | 1.142 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 7.203271e-02 | 1.142 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.967721e-01 | 0.706 | 0 | 0 |
| Defective ABCB6 causes MCOPCB7 | R-HSA-5683371 | 1.967721e-01 | 0.706 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.049617e-01 | 0.979 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.049617e-01 | 0.979 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 1.049617e-01 | 0.979 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.049617e-01 | 0.979 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.049617e-01 | 0.979 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 2.395953e-01 | 0.621 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 2.395953e-01 | 0.621 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.395953e-01 | 0.621 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.395953e-01 | 0.621 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 2.395953e-01 | 0.621 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 2.395953e-01 | 0.621 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 2.395953e-01 | 0.621 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.410522e-01 | 0.851 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.410522e-01 | 0.851 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 2.801379e-01 | 0.553 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.801379e-01 | 0.553 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.801379e-01 | 0.553 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.801379e-01 | 0.553 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.801379e-01 | 0.553 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.801379e-01 | 0.553 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.782498e-02 | 1.056 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.782498e-02 | 1.056 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.782498e-02 | 1.056 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.599606e-01 | 0.796 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.976817e-02 | 1.156 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.097849e-01 | 0.959 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.792953e-01 | 0.746 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.185212e-01 | 0.497 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.185212e-01 | 0.497 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.185212e-01 | 0.497 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.185212e-01 | 0.497 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.989572e-01 | 0.701 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.989572e-01 | 0.701 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.010394e-01 | 0.996 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.461296e-01 | 0.835 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.188568e-01 | 0.660 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.548601e-01 | 0.450 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.548601e-01 | 0.450 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 3.548601e-01 | 0.450 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 3.548601e-01 | 0.450 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.548601e-01 | 0.450 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.097171e-01 | 0.960 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.097171e-01 | 0.960 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.097171e-01 | 0.960 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.354263e-02 | 1.078 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.187153e-01 | 0.925 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.187153e-01 | 0.925 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.187153e-01 | 0.925 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.187153e-01 | 0.925 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.412448e-02 | 1.130 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.376205e-01 | 0.861 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.892634e-01 | 0.410 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.892634e-01 | 0.410 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 3.892634e-01 | 0.410 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 3.892634e-01 | 0.410 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.892634e-01 | 0.410 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 3.892634e-01 | 0.410 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 3.892634e-01 | 0.410 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.892634e-01 | 0.410 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.892634e-01 | 0.410 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 3.892634e-01 | 0.410 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.995373e-01 | 0.700 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.186768e-01 | 0.926 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.792096e-01 | 0.554 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.792096e-01 | 0.554 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.135523e-01 | 0.670 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.135523e-01 | 0.670 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.277691e-01 | 0.643 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.993253e-01 | 0.524 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.218339e-01 | 0.375 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.218339e-01 | 0.375 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 4.218339e-01 | 0.375 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 4.218339e-01 | 0.375 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.217341e-01 | 0.915 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.989701e-02 | 1.046 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.100320e-01 | 0.958 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.193469e-01 | 0.496 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.427108e-01 | 0.846 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.117915e-01 | 0.674 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.773911e-01 | 0.751 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.773911e-01 | 0.751 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.023008e-02 | 1.153 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.713322e-01 | 0.566 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.713322e-01 | 0.566 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.392271e-01 | 0.470 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.526694e-01 | 0.344 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.526694e-01 | 0.344 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.589243e-01 | 0.445 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.346819e-01 | 0.630 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.784015e-01 | 0.422 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.784015e-01 | 0.422 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.818621e-01 | 0.317 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.818621e-01 | 0.317 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.818621e-01 | 0.317 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.305254e-01 | 0.481 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.548379e-01 | 0.594 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.871308e-01 | 0.728 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.165699e-01 | 0.380 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.165699e-01 | 0.380 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.962763e-01 | 0.528 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.962763e-01 | 0.528 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.352081e-01 | 0.361 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.514463e-01 | 0.600 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.555692e-01 | 0.449 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.845332e-01 | 0.546 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.535194e-01 | 0.343 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.535194e-01 | 0.343 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.494093e-01 | 0.457 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.494093e-01 | 0.457 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.187680e-01 | 0.497 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.714857e-01 | 0.327 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.714857e-01 | 0.327 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.815707e-01 | 0.418 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.624459e-01 | 0.441 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.288696e-01 | 0.368 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.701724e-01 | 0.432 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.701724e-01 | 0.432 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.560252e-01 | 0.341 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.768917e-01 | 0.322 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.029901e-01 | 0.395 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.895884e-01 | 0.409 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.010394e-01 | 0.996 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.186768e-01 | 0.926 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.124768e-01 | 0.949 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.165699e-01 | 0.380 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.376205e-01 | 0.861 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.008558e-01 | 0.522 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.404660e-01 | 0.619 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.494285e-01 | 0.826 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.722380e-01 | 0.764 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.579721e-01 | 0.339 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.117915e-01 | 0.674 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.186768e-01 | 0.926 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.174067e-01 | 0.498 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.599606e-01 | 0.796 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.989572e-01 | 0.701 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.336053e-01 | 0.874 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.376205e-01 | 0.861 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.253662e-02 | 1.139 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.773911e-01 | 0.751 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.773911e-01 | 0.751 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.773911e-01 | 0.751 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.309976e-01 | 0.480 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.187403e-01 | 0.497 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.292288e-01 | 0.640 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.097849e-01 | 0.959 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.601577e-01 | 0.444 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.057547e-01 | 0.687 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.762393e-02 | 1.110 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.782498e-02 | 1.056 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.599606e-01 | 0.796 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.111601e-01 | 0.954 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.392271e-01 | 0.470 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.582836e-01 | 0.588 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.624459e-01 | 0.441 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.753123e-01 | 0.323 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.389379e-01 | 0.358 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.445336e-01 | 0.463 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.010394e-01 | 0.996 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 9.685028e-02 | 1.014 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.309976e-01 | 0.480 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.376205e-01 | 0.861 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.352081e-01 | 0.361 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.525217e-01 | 0.453 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.753123e-01 | 0.323 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 8.803137e-02 | 1.055 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.801379e-01 | 0.553 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.989572e-01 | 0.701 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 3.548601e-01 | 0.450 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.857552e-01 | 0.731 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.193469e-01 | 0.496 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.589243e-01 | 0.445 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.247785e-01 | 0.648 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.818621e-01 | 0.317 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.753123e-01 | 0.323 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.470874e-02 | 1.127 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.381132e-02 | 1.132 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.142611e-01 | 0.669 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.784015e-01 | 0.422 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.512702e-01 | 0.600 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.269473e-02 | 1.033 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.188568e-01 | 0.660 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.344014e-01 | 0.872 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.332391e-01 | 0.477 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.376205e-01 | 0.861 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.673484e-01 | 0.776 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.736487e-01 | 0.760 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 1.410522e-01 | 0.851 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.792953e-01 | 0.746 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 1.792953e-01 | 0.746 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.185212e-01 | 0.497 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.188568e-01 | 0.660 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.792096e-01 | 0.554 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.218339e-01 | 0.375 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.094030e-02 | 1.092 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.193469e-01 | 0.496 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.773911e-01 | 0.751 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.976262e-01 | 0.401 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.976262e-01 | 0.401 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.165699e-01 | 0.380 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.164886e-01 | 0.665 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.274413e-01 | 0.485 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.330443e-01 | 0.363 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.652207e-01 | 0.782 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.404660e-01 | 0.619 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.188568e-01 | 0.660 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.995373e-01 | 0.700 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.895742e-02 | 1.005 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.566878e-01 | 0.591 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.254181e-01 | 0.371 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.410522e-01 | 0.851 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.548601e-01 | 0.450 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 3.892634e-01 | 0.410 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 3.892634e-01 | 0.410 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.995373e-01 | 0.700 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.566878e-01 | 0.591 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.536134e-01 | 0.814 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.818621e-01 | 0.317 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.165699e-01 | 0.380 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.068150e-01 | 0.513 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.142119e-01 | 0.503 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.535194e-01 | 0.343 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.753123e-01 | 0.323 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.560252e-01 | 0.341 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.650710e-01 | 0.577 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.895884e-01 | 0.409 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.472834e-01 | 0.349 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.293727e-01 | 0.367 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.536134e-01 | 0.814 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 8.803137e-02 | 1.055 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.231974e-01 | 0.651 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.976262e-01 | 0.401 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.217353e-01 | 0.915 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.765436e-01 | 0.322 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.410522e-01 | 0.851 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.713322e-01 | 0.566 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.380101e-01 | 0.860 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.714857e-01 | 0.327 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.792096e-01 | 0.554 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.995373e-01 | 0.700 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.421574e-01 | 0.616 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.115392e-01 | 0.675 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.515402e-01 | 0.819 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.967721e-01 | 0.706 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.801379e-01 | 0.553 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.801379e-01 | 0.553 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.599606e-01 | 0.796 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.989572e-01 | 0.701 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.989572e-01 | 0.701 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.548601e-01 | 0.450 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.548601e-01 | 0.450 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.548601e-01 | 0.450 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.548601e-01 | 0.450 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.548601e-01 | 0.450 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.548601e-01 | 0.450 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.389129e-01 | 0.622 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.280210e-01 | 0.893 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.857552e-01 | 0.731 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.852624e-02 | 1.053 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.277691e-01 | 0.643 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 4.218339e-01 | 0.375 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.509988e-01 | 0.821 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.895084e-01 | 0.722 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.392271e-01 | 0.470 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.784015e-01 | 0.422 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.818621e-01 | 0.317 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.305254e-01 | 0.481 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.749077e-01 | 0.426 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.280422e-01 | 0.484 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.167613e-01 | 0.380 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.664895e-01 | 0.331 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.032194e-01 | 0.692 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.509988e-01 | 0.821 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.289017e-01 | 0.483 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.601577e-01 | 0.444 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.589243e-01 | 0.445 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.186768e-01 | 0.926 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.494257e-02 | 1.071 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.684056e-01 | 0.774 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.773911e-01 | 0.751 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.782498e-02 | 1.056 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.037028e-01 | 0.691 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.243205e-01 | 0.372 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.792096e-01 | 0.554 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.680359e-01 | 0.775 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.438060e-01 | 0.353 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.187479e-01 | 0.925 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.438060e-01 | 0.353 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.681650e-01 | 0.330 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.005566e-01 | 0.698 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.469500e-01 | 0.833 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.410522e-01 | 0.851 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.722380e-01 | 0.764 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.590524e-01 | 0.587 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.526694e-01 | 0.344 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.822437e-01 | 0.549 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.920259e-02 | 1.003 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.065197e-01 | 0.514 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.170651e-01 | 0.663 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.681650e-01 | 0.330 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.854934e-02 | 1.053 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.753949e-01 | 0.560 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.909121e-01 | 0.408 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.664895e-01 | 0.331 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.117915e-01 | 0.674 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.185212e-01 | 0.497 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.127382e-02 | 1.147 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.937839e-02 | 1.100 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.218339e-01 | 0.375 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.650710e-01 | 0.577 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.753949e-01 | 0.560 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.702169e-01 | 0.568 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.943495e-01 | 0.531 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.538745e-01 | 0.451 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.538745e-01 | 0.451 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.851811e-02 | 1.053 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.135789e-01 | 0.504 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.067975e-01 | 0.684 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.280210e-01 | 0.893 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.186724e-01 | 0.378 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.844106e-01 | 0.734 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.523981e-01 | 0.453 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.037641e-02 | 1.153 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.110395e-01 | 0.507 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.015978e-01 | 0.993 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.187403e-01 | 0.497 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.888926e-01 | 0.410 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.536577e-01 | 0.451 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.355546e-02 | 1.078 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.382656e-01 | 0.623 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.518166e-01 | 0.599 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.188568e-01 | 0.660 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.057547e-01 | 0.687 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.581111e-01 | 0.446 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.118198e-01 | 0.951 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.199748e-01 | 0.495 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.747629e-01 | 0.758 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.747629e-01 | 0.758 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.274761e-01 | 0.369 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.395953e-01 | 0.621 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.892634e-01 | 0.410 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.135523e-01 | 0.670 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.218339e-01 | 0.375 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.218339e-01 | 0.375 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.526694e-01 | 0.344 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.526694e-01 | 0.344 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.526694e-01 | 0.344 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.526694e-01 | 0.344 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.589243e-01 | 0.445 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.784015e-01 | 0.422 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.818621e-01 | 0.317 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.555495e-01 | 0.593 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.523981e-01 | 0.453 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.588271e-01 | 0.799 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.590016e-02 | 1.018 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.050482e-01 | 0.688 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.009175e-01 | 0.522 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.506370e-01 | 0.601 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.661778e-01 | 0.779 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.523981e-01 | 0.453 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.492865e-01 | 0.826 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.891231e-01 | 0.723 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.546451e-01 | 0.811 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.537433e-01 | 0.813 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.590184e-01 | 0.799 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.500503e-01 | 0.824 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.070059e-01 | 0.971 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.286510e-01 | 0.368 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.008558e-01 | 0.522 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.156843e-01 | 0.501 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.041821e-01 | 0.393 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.674336e-01 | 0.776 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.531119e-01 | 0.597 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.464591e-01 | 0.608 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.800680e-01 | 0.420 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.860314e-01 | 0.544 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.620113e-01 | 0.441 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.041821e-01 | 0.393 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.086862e-01 | 0.389 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.803137e-02 | 1.055 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.727647e-02 | 1.112 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.892634e-01 | 0.410 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.680359e-01 | 0.775 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.818621e-01 | 0.317 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.650710e-01 | 0.577 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.555692e-01 | 0.449 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.647563e-01 | 0.333 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.659045e-01 | 0.332 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.815707e-01 | 0.418 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 3.976262e-01 | 0.401 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.613767e-01 | 0.336 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.481442e-01 | 0.349 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.888926e-01 | 0.410 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.888926e-01 | 0.410 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.888926e-01 | 0.410 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.722380e-01 | 0.764 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.612598e-01 | 0.336 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.029111e-01 | 0.395 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.493803e-01 | 0.603 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.610351e-01 | 0.442 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.458310e-01 | 0.461 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.153665e-01 | 0.382 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.702636e-01 | 0.568 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.800680e-01 | 0.420 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.953681e-01 | 0.530 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.389129e-01 | 0.622 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.264263e-01 | 0.898 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.993253e-01 | 0.524 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.218339e-01 | 0.375 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.218339e-01 | 0.375 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.526694e-01 | 0.344 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.526694e-01 | 0.344 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.818621e-01 | 0.317 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 4.041821e-01 | 0.393 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.288696e-01 | 0.368 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.613767e-01 | 0.336 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.537520e-01 | 0.343 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.382647e-01 | 0.471 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.356480e-01 | 0.361 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.047598e-01 | 0.689 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.305254e-01 | 0.481 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.680359e-01 | 0.775 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.749077e-01 | 0.426 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.494093e-01 | 0.457 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.599606e-01 | 0.796 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.947178e-01 | 0.404 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.227169e-01 | 0.652 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.203271e-02 | 1.142 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.049617e-01 | 0.979 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.226793e-01 | 0.911 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.548601e-01 | 0.450 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.792096e-01 | 0.554 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.792096e-01 | 0.554 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.218339e-01 | 0.375 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.218339e-01 | 0.375 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.526694e-01 | 0.344 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.404274e-01 | 0.853 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.818621e-01 | 0.317 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.818621e-01 | 0.317 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.818621e-01 | 0.317 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.086546e-01 | 0.964 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 4.714857e-01 | 0.327 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.197822e-01 | 0.377 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.913403e-01 | 0.536 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.327060e-02 | 1.080 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.862634e-01 | 0.543 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.713322e-01 | 0.566 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.436022e-01 | 0.613 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.851732e-01 | 0.414 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.684056e-01 | 0.774 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.117915e-01 | 0.674 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.432781e-01 | 0.464 | 1 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.704913e-02 | 1.113 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.117915e-01 | 0.674 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.526694e-01 | 0.344 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.818621e-01 | 0.317 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.976262e-01 | 0.401 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.601577e-01 | 0.444 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.176781e-01 | 0.498 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.941639e-01 | 0.712 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.664895e-01 | 0.331 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.857552e-01 | 0.731 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.296009e-01 | 0.482 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.813188e-01 | 0.419 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.943495e-01 | 0.531 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.973733e-01 | 0.705 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.387127e-01 | 0.470 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.535194e-01 | 0.343 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.187403e-01 | 0.497 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.187403e-01 | 0.497 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.006866e-02 | 1.045 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.252079e-01 | 0.902 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.218339e-01 | 0.375 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 4.352081e-01 | 0.361 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.525409e-01 | 0.453 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.428053e-01 | 0.465 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.111601e-01 | 0.954 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.601577e-01 | 0.444 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.719512e-01 | 0.765 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.156843e-01 | 0.501 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.818621e-01 | 0.317 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 3.678582e-01 | 0.434 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.392271e-01 | 0.470 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.784015e-01 | 0.422 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.818621e-01 | 0.317 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.753123e-01 | 0.323 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.714857e-01 | 0.327 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.407781e-01 | 0.618 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.895884e-01 | 0.409 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.232955e-01 | 0.651 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.852254e-01 | 0.314 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.862115e-01 | 0.313 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.872260e-01 | 0.312 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.872260e-01 | 0.312 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.882300e-01 | 0.311 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.890790e-01 | 0.311 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.890917e-01 | 0.311 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.890917e-01 | 0.311 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.890917e-01 | 0.311 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.890917e-01 | 0.311 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.938122e-01 | 0.306 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.998084e-01 | 0.301 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.023547e-01 | 0.299 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.026669e-01 | 0.299 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.026669e-01 | 0.299 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.026669e-01 | 0.299 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.026669e-01 | 0.299 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.026669e-01 | 0.299 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.026669e-01 | 0.299 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.038357e-01 | 0.298 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.063249e-01 | 0.296 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 5.063249e-01 | 0.296 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.063249e-01 | 0.296 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.063249e-01 | 0.296 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.063249e-01 | 0.296 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.063249e-01 | 0.296 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.076691e-01 | 0.294 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.076691e-01 | 0.294 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.094994e-01 | 0.293 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.094994e-01 | 0.293 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.094994e-01 | 0.293 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.094994e-01 | 0.293 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 5.094994e-01 | 0.293 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.094994e-01 | 0.293 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.094994e-01 | 0.293 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.094994e-01 | 0.293 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.094994e-01 | 0.293 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.094994e-01 | 0.293 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.108962e-01 | 0.292 | 1 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.112718e-01 | 0.291 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.112718e-01 | 0.291 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.112718e-01 | 0.291 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.112718e-01 | 0.291 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.112718e-01 | 0.291 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.112718e-01 | 0.291 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 5.112718e-01 | 0.291 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.139707e-01 | 0.289 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.160933e-01 | 0.287 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.226140e-01 | 0.282 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.226140e-01 | 0.282 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.231748e-01 | 0.281 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.231748e-01 | 0.281 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.231748e-01 | 0.281 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.231748e-01 | 0.281 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.231748e-01 | 0.281 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.276852e-01 | 0.278 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.292703e-01 | 0.276 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.338289e-01 | 0.273 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.338289e-01 | 0.273 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.356641e-01 | 0.271 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.356641e-01 | 0.271 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.356641e-01 | 0.271 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.356641e-01 | 0.271 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.356641e-01 | 0.271 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.356641e-01 | 0.271 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.356641e-01 | 0.271 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 5.356641e-01 | 0.271 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.356641e-01 | 0.271 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.356641e-01 | 0.271 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.360195e-01 | 0.271 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.396334e-01 | 0.268 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.396334e-01 | 0.268 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.396334e-01 | 0.268 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.396334e-01 | 0.268 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.460193e-01 | 0.263 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.485296e-01 | 0.261 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.525074e-01 | 0.258 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.550602e-01 | 0.256 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.550602e-01 | 0.256 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.550602e-01 | 0.256 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.550602e-01 | 0.256 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.556944e-01 | 0.255 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.556944e-01 | 0.255 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.558557e-01 | 0.255 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.571723e-01 | 0.254 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.571723e-01 | 0.254 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.604347e-01 | 0.251 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.604347e-01 | 0.251 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.604347e-01 | 0.251 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.604347e-01 | 0.251 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 5.604347e-01 | 0.251 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.604347e-01 | 0.251 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.604347e-01 | 0.251 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.604347e-01 | 0.251 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.604347e-01 | 0.251 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.604347e-01 | 0.251 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.604347e-01 | 0.251 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 5.604347e-01 | 0.251 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.666578e-01 | 0.247 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.676332e-01 | 0.246 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.676341e-01 | 0.246 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.676341e-01 | 0.246 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.700274e-01 | 0.244 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.713535e-01 | 0.243 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.713535e-01 | 0.243 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.713535e-01 | 0.243 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.713535e-01 | 0.243 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.713535e-01 | 0.243 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.713535e-01 | 0.243 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.762978e-01 | 0.239 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.767488e-01 | 0.239 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.784818e-01 | 0.238 | 0 | 0 |
| Translation | R-HSA-72766 | 5.806940e-01 | 0.236 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.838852e-01 | 0.234 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 5.838852e-01 | 0.234 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.838852e-01 | 0.234 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.838852e-01 | 0.234 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.838852e-01 | 0.234 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.838852e-01 | 0.234 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.838852e-01 | 0.234 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.838852e-01 | 0.234 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.838852e-01 | 0.234 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.838852e-01 | 0.234 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.838852e-01 | 0.234 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.838852e-01 | 0.234 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.838852e-01 | 0.234 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.848750e-01 | 0.233 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.848750e-01 | 0.233 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.857556e-01 | 0.232 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.866077e-01 | 0.232 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.878179e-01 | 0.231 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.921147e-01 | 0.228 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.921147e-01 | 0.228 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.921147e-01 | 0.228 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.933623e-01 | 0.227 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.950376e-01 | 0.225 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.993594e-01 | 0.222 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.996050e-01 | 0.222 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.996181e-01 | 0.222 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.014558e-01 | 0.221 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.014558e-01 | 0.221 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.017574e-01 | 0.221 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.017574e-01 | 0.221 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.040135e-01 | 0.219 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.040135e-01 | 0.219 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.040135e-01 | 0.219 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.040135e-01 | 0.219 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.060860e-01 | 0.217 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.060860e-01 | 0.217 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.060860e-01 | 0.217 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.060860e-01 | 0.217 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.060860e-01 | 0.217 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.060860e-01 | 0.217 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.060860e-01 | 0.217 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.060860e-01 | 0.217 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.060860e-01 | 0.217 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.080593e-01 | 0.216 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.156802e-01 | 0.211 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.156802e-01 | 0.211 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.158977e-01 | 0.210 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.158977e-01 | 0.210 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.158977e-01 | 0.210 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.158977e-01 | 0.210 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.183954e-01 | 0.209 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.183954e-01 | 0.209 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.263037e-01 | 0.203 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 6.271036e-01 | 0.203 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.271036e-01 | 0.203 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.271036e-01 | 0.203 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.271036e-01 | 0.203 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.271036e-01 | 0.203 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.271036e-01 | 0.203 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.271036e-01 | 0.203 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.271036e-01 | 0.203 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.271036e-01 | 0.203 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.271036e-01 | 0.203 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.271036e-01 | 0.203 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.299343e-01 | 0.201 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.299343e-01 | 0.201 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.299343e-01 | 0.201 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.299343e-01 | 0.201 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.299343e-01 | 0.201 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.301628e-01 | 0.201 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.343736e-01 | 0.198 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.343736e-01 | 0.198 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.379727e-01 | 0.195 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.379727e-01 | 0.195 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.383085e-01 | 0.195 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.383085e-01 | 0.195 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.383085e-01 | 0.195 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.383085e-01 | 0.195 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.383085e-01 | 0.195 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.396462e-01 | 0.194 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.435679e-01 | 0.191 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.470010e-01 | 0.189 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.470010e-01 | 0.189 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.470010e-01 | 0.189 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.470010e-01 | 0.189 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.470010e-01 | 0.189 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.470010e-01 | 0.189 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.470010e-01 | 0.189 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.470010e-01 | 0.189 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.470010e-01 | 0.189 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.470010e-01 | 0.189 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.470010e-01 | 0.189 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.470010e-01 | 0.189 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.470010e-01 | 0.189 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.470010e-01 | 0.189 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.470010e-01 | 0.189 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.470010e-01 | 0.189 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.492668e-01 | 0.188 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.492668e-01 | 0.188 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.492668e-01 | 0.188 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.492668e-01 | 0.188 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.500784e-01 | 0.187 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.531087e-01 | 0.185 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.568015e-01 | 0.183 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.568015e-01 | 0.183 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.568015e-01 | 0.183 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 6.568015e-01 | 0.183 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.568015e-01 | 0.183 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.568015e-01 | 0.183 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.568015e-01 | 0.183 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.568015e-01 | 0.183 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.599867e-01 | 0.180 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.648984e-01 | 0.177 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.658378e-01 | 0.177 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.658378e-01 | 0.177 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.658378e-01 | 0.177 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.658378e-01 | 0.177 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.658378e-01 | 0.177 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.658378e-01 | 0.177 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.658378e-01 | 0.177 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.660873e-01 | 0.176 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.667766e-01 | 0.176 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.696389e-01 | 0.174 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.704676e-01 | 0.174 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.735149e-01 | 0.172 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.751200e-01 | 0.171 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.802251e-01 | 0.167 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.802546e-01 | 0.167 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.807098e-01 | 0.167 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.820848e-01 | 0.166 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.820848e-01 | 0.166 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 6.820848e-01 | 0.166 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.820848e-01 | 0.166 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.820848e-01 | 0.166 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.832947e-01 | 0.165 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.836706e-01 | 0.165 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.836706e-01 | 0.165 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 6.836706e-01 | 0.165 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 6.836706e-01 | 0.165 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.836706e-01 | 0.165 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.836706e-01 | 0.165 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.836706e-01 | 0.165 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.836706e-01 | 0.165 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.836706e-01 | 0.165 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.836706e-01 | 0.165 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.907135e-01 | 0.161 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.926724e-01 | 0.159 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.941442e-01 | 0.159 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.941442e-01 | 0.159 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.941442e-01 | 0.159 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.005527e-01 | 0.155 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.005527e-01 | 0.155 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.005527e-01 | 0.155 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.005527e-01 | 0.155 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.005527e-01 | 0.155 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.005527e-01 | 0.155 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.020493e-01 | 0.154 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.058231e-01 | 0.151 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.076024e-01 | 0.150 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.100094e-01 | 0.149 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.165348e-01 | 0.145 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.165348e-01 | 0.145 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.165348e-01 | 0.145 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.165348e-01 | 0.145 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.165348e-01 | 0.145 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.165348e-01 | 0.145 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.165348e-01 | 0.145 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.165348e-01 | 0.145 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.165348e-01 | 0.145 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.165348e-01 | 0.145 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.171277e-01 | 0.144 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.171277e-01 | 0.144 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.177152e-01 | 0.144 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.185596e-01 | 0.144 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.191923e-01 | 0.143 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.221815e-01 | 0.141 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.241297e-01 | 0.140 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.264118e-01 | 0.139 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.280646e-01 | 0.138 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.280646e-01 | 0.138 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.280646e-01 | 0.138 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.280646e-01 | 0.138 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.283658e-01 | 0.138 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.316648e-01 | 0.136 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.316648e-01 | 0.136 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.316648e-01 | 0.136 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.316648e-01 | 0.136 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.316648e-01 | 0.136 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.316648e-01 | 0.136 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.316648e-01 | 0.136 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.316648e-01 | 0.136 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.316648e-01 | 0.136 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.316648e-01 | 0.136 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.316648e-01 | 0.136 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.316648e-01 | 0.136 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.334968e-01 | 0.135 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.335558e-01 | 0.135 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.371963e-01 | 0.132 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.371963e-01 | 0.132 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.371963e-01 | 0.132 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.371963e-01 | 0.132 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.371963e-01 | 0.132 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.386409e-01 | 0.132 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.386409e-01 | 0.132 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.412215e-01 | 0.130 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.441659e-01 | 0.128 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.457981e-01 | 0.127 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.457981e-01 | 0.127 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.459881e-01 | 0.127 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.459881e-01 | 0.127 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.459881e-01 | 0.127 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.459881e-01 | 0.127 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.459881e-01 | 0.127 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.459881e-01 | 0.127 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.459881e-01 | 0.127 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.459881e-01 | 0.127 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.459881e-01 | 0.127 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.459881e-01 | 0.127 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.470323e-01 | 0.127 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.487187e-01 | 0.126 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.488639e-01 | 0.126 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.488639e-01 | 0.126 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.488639e-01 | 0.126 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.488639e-01 | 0.126 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.538379e-01 | 0.123 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.560485e-01 | 0.121 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.587412e-01 | 0.120 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.589781e-01 | 0.120 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.595477e-01 | 0.119 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.595477e-01 | 0.119 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.595477e-01 | 0.119 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.595477e-01 | 0.119 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.618599e-01 | 0.118 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.629776e-01 | 0.117 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.646152e-01 | 0.117 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.682805e-01 | 0.114 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.682805e-01 | 0.114 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.702110e-01 | 0.113 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 7.723842e-01 | 0.112 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.723842e-01 | 0.112 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.723842e-01 | 0.112 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.723842e-01 | 0.112 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.723842e-01 | 0.112 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.732044e-01 | 0.112 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.746943e-01 | 0.111 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.774898e-01 | 0.109 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.774898e-01 | 0.109 | 0 | 0 |
| Methylation | R-HSA-156581 | 7.774898e-01 | 0.109 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.774898e-01 | 0.109 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.774898e-01 | 0.109 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.845362e-01 | 0.105 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.845362e-01 | 0.105 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.845362e-01 | 0.105 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.845362e-01 | 0.105 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.845362e-01 | 0.105 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.853885e-01 | 0.105 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.863770e-01 | 0.104 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.863770e-01 | 0.104 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.863770e-01 | 0.104 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.902349e-01 | 0.102 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.939196e-01 | 0.100 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.949504e-01 | 0.100 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.949504e-01 | 0.100 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.952788e-01 | 0.099 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.960401e-01 | 0.099 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 7.960401e-01 | 0.099 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.960401e-01 | 0.099 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.998399e-01 | 0.097 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.998399e-01 | 0.097 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.032180e-01 | 0.095 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.032180e-01 | 0.095 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.032180e-01 | 0.095 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.067173e-01 | 0.093 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.067173e-01 | 0.093 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.067173e-01 | 0.093 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.067173e-01 | 0.093 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.069304e-01 | 0.093 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.069304e-01 | 0.093 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.069304e-01 | 0.093 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.069304e-01 | 0.093 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.069304e-01 | 0.093 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.069304e-01 | 0.093 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.069304e-01 | 0.093 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.088372e-01 | 0.092 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.111881e-01 | 0.091 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.113429e-01 | 0.091 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.133944e-01 | 0.090 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.147312e-01 | 0.089 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.160405e-01 | 0.088 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.172399e-01 | 0.088 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.172399e-01 | 0.088 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.172399e-01 | 0.088 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.172399e-01 | 0.088 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.172399e-01 | 0.088 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.172399e-01 | 0.088 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.172399e-01 | 0.088 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.172399e-01 | 0.088 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.188688e-01 | 0.087 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.188688e-01 | 0.087 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.188688e-01 | 0.087 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.188688e-01 | 0.087 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.195703e-01 | 0.086 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.198752e-01 | 0.086 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.215600e-01 | 0.085 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.262683e-01 | 0.083 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.269995e-01 | 0.082 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.269995e-01 | 0.082 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.269995e-01 | 0.082 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.269995e-01 | 0.082 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.269995e-01 | 0.082 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.269995e-01 | 0.082 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.269995e-01 | 0.082 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.333948e-01 | 0.079 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.333948e-01 | 0.079 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.340047e-01 | 0.079 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.362385e-01 | 0.078 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.362385e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.362385e-01 | 0.078 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.362385e-01 | 0.078 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.362385e-01 | 0.078 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.362385e-01 | 0.078 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.362385e-01 | 0.078 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.362385e-01 | 0.078 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.366958e-01 | 0.077 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.368316e-01 | 0.077 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.368541e-01 | 0.077 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.402563e-01 | 0.076 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.402563e-01 | 0.076 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.417903e-01 | 0.075 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.419993e-01 | 0.075 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.424363e-01 | 0.074 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.449845e-01 | 0.073 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.449845e-01 | 0.073 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.468606e-01 | 0.072 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.494677e-01 | 0.071 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.509008e-01 | 0.070 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.532158e-01 | 0.069 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.532640e-01 | 0.069 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.566826e-01 | 0.067 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.569347e-01 | 0.067 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.600663e-01 | 0.065 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.611018e-01 | 0.065 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.611018e-01 | 0.065 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.611018e-01 | 0.065 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.611018e-01 | 0.065 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.611018e-01 | 0.065 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.611289e-01 | 0.065 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.652096e-01 | 0.063 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.658131e-01 | 0.063 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.685213e-01 | 0.061 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.685213e-01 | 0.061 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.685213e-01 | 0.061 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.685213e-01 | 0.061 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.693015e-01 | 0.061 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.708633e-01 | 0.060 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.729924e-01 | 0.059 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.755450e-01 | 0.058 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.755450e-01 | 0.058 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.755450e-01 | 0.058 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.785712e-01 | 0.056 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.785712e-01 | 0.056 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.815214e-01 | 0.055 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.815214e-01 | 0.055 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 8.815214e-01 | 0.055 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.821938e-01 | 0.054 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.821938e-01 | 0.054 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.821938e-01 | 0.054 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.821938e-01 | 0.054 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.821938e-01 | 0.054 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.837437e-01 | 0.054 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.884878e-01 | 0.051 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.884878e-01 | 0.051 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.884878e-01 | 0.051 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 8.884878e-01 | 0.051 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.884878e-01 | 0.051 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.884878e-01 | 0.051 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.889536e-01 | 0.051 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.944460e-01 | 0.048 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 8.944460e-01 | 0.048 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.944460e-01 | 0.048 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.944460e-01 | 0.048 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.944460e-01 | 0.048 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.944460e-01 | 0.048 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.944460e-01 | 0.048 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.944460e-01 | 0.048 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.944460e-01 | 0.048 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.948433e-01 | 0.048 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.980461e-01 | 0.047 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.983400e-01 | 0.047 | 1 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.994585e-01 | 0.046 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.998283e-01 | 0.046 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.000861e-01 | 0.046 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.000861e-01 | 0.046 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.000861e-01 | 0.046 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.000861e-01 | 0.046 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.004373e-01 | 0.046 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.012233e-01 | 0.045 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.037824e-01 | 0.044 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.043142e-01 | 0.044 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.047055e-01 | 0.043 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.054251e-01 | 0.043 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.054251e-01 | 0.043 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.054251e-01 | 0.043 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.054251e-01 | 0.043 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.060013e-01 | 0.043 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.073949e-01 | 0.042 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.073949e-01 | 0.042 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.088022e-01 | 0.042 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.104792e-01 | 0.041 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.104792e-01 | 0.041 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.104792e-01 | 0.041 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.152635e-01 | 0.038 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.152635e-01 | 0.038 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.152635e-01 | 0.038 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.159489e-01 | 0.038 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.166568e-01 | 0.038 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.197923e-01 | 0.036 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.197923e-01 | 0.036 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.197923e-01 | 0.036 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.197923e-01 | 0.036 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.201240e-01 | 0.036 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.236778e-01 | 0.034 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.236778e-01 | 0.034 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.236795e-01 | 0.034 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.240794e-01 | 0.034 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.240794e-01 | 0.034 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.240794e-01 | 0.034 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.240794e-01 | 0.034 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.240794e-01 | 0.034 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.269225e-01 | 0.033 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.281376e-01 | 0.032 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.281376e-01 | 0.032 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.281376e-01 | 0.032 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.281376e-01 | 0.032 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.301133e-01 | 0.031 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.319790e-01 | 0.031 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.319790e-01 | 0.031 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.319790e-01 | 0.031 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.319790e-01 | 0.031 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.321447e-01 | 0.031 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.321447e-01 | 0.031 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.331721e-01 | 0.030 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.350607e-01 | 0.029 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.356154e-01 | 0.029 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.356154e-01 | 0.029 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.373398e-01 | 0.028 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.394886e-01 | 0.027 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.416054e-01 | 0.026 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.423159e-01 | 0.026 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.423159e-01 | 0.026 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.423159e-01 | 0.026 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.423159e-01 | 0.026 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.423159e-01 | 0.026 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.423159e-01 | 0.026 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.454002e-01 | 0.024 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.454002e-01 | 0.024 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.454002e-01 | 0.024 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.461064e-01 | 0.024 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.477854e-01 | 0.023 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.477854e-01 | 0.023 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.477854e-01 | 0.023 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.478017e-01 | 0.023 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.479861e-01 | 0.023 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.483198e-01 | 0.023 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.486439e-01 | 0.023 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.490208e-01 | 0.023 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.490208e-01 | 0.023 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.490208e-01 | 0.023 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.506703e-01 | 0.022 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.510834e-01 | 0.022 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.510834e-01 | 0.022 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.512865e-01 | 0.022 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.536652e-01 | 0.021 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.536994e-01 | 0.021 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.561756e-01 | 0.019 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.585196e-01 | 0.018 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.597295e-01 | 0.018 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.607383e-01 | 0.017 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.607383e-01 | 0.017 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.611918e-01 | 0.017 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.625810e-01 | 0.017 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.648264e-01 | 0.016 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.658270e-01 | 0.015 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.684893e-01 | 0.014 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.684893e-01 | 0.014 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.701634e-01 | 0.013 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 9.701753e-01 | 0.013 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.701753e-01 | 0.013 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.701753e-01 | 0.013 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.701753e-01 | 0.013 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.732817e-01 | 0.012 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.732817e-01 | 0.012 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.734651e-01 | 0.012 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.751634e-01 | 0.011 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.760649e-01 | 0.011 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.760649e-01 | 0.011 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.773459e-01 | 0.010 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.777169e-01 | 0.010 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.780678e-01 | 0.010 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.781242e-01 | 0.010 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.801648e-01 | 0.009 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.803995e-01 | 0.009 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.807204e-01 | 0.008 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.807925e-01 | 0.008 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.808790e-01 | 0.008 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.809892e-01 | 0.008 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.821686e-01 | 0.008 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.824557e-01 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.827940e-01 | 0.008 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.837153e-01 | 0.007 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.837153e-01 | 0.007 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.837153e-01 | 0.007 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.845872e-01 | 0.007 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.849137e-01 | 0.007 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.852540e-01 | 0.006 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.861937e-01 | 0.006 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.861937e-01 | 0.006 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.869330e-01 | 0.006 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.869330e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.869330e-01 | 0.006 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.869554e-01 | 0.006 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.870728e-01 | 0.006 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.874138e-01 | 0.006 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.882952e-01 | 0.005 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.895156e-01 | 0.005 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.895156e-01 | 0.005 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.895460e-01 | 0.005 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.906088e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.906088e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.908711e-01 | 0.004 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.915882e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.916373e-01 | 0.004 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.916373e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.916373e-01 | 0.004 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.924655e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.924655e-01 | 0.003 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.928693e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.932514e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.932582e-01 | 0.003 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.944462e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.947528e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.948601e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.948763e-01 | 0.002 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.951510e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.955049e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.956571e-01 | 0.002 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.960260e-01 | 0.002 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.962436e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.963189e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.963189e-01 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.968532e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.968727e-01 | 0.001 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.969154e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.971980e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.972058e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.974976e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.976318e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.978608e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.984768e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.986028e-01 | 0.001 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.986360e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.986654e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.987092e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.987785e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.988441e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.989554e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.991044e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.991700e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.992568e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.993130e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.994664e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.994733e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.995722e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.996325e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.996376e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.996443e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.997488e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.997488e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998865e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.998944e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.998982e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999140e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999337e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999381e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999707e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999718e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999732e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999746e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999746e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999788e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999805e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999807e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999841e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999889e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999905e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999952e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999974e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999999e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.000000e+00 | 0.000 | 1 | 1 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by Activin | R-HSA-1502540 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by BMP | R-HSA-201451 | 1.000000e+00 | 0.000 | 1 | 1 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.376677e-14 | 13.861 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.395107e-12 | 11.194 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.317202e-11 | 10.479 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.280487e-11 | 10.032 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.357560e-10 | 9.867 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.894596e-10 | 9.722 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.134626e-09 | 8.945 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.134626e-09 | 8.945 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.370304e-09 | 8.863 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.370304e-09 | 8.863 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.091029e-09 | 8.041 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.006610e-08 | 7.997 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.202940e-08 | 7.920 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.797854e-08 | 7.745 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.078979e-08 | 7.682 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.401503e-08 | 7.620 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.279283e-08 | 7.484 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.617230e-08 | 7.017 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.206805e-07 | 6.918 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.652964e-07 | 6.782 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.813038e-07 | 6.742 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.018964e-07 | 6.695 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.461083e-07 | 6.461 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.947396e-07 | 6.404 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.278248e-07 | 6.278 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.001122e-06 | 6.000 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.999259e-07 | 6.000 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.112337e-06 | 5.954 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.333022e-06 | 5.875 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.340236e-06 | 5.873 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.294328e-06 | 5.888 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.496572e-06 | 5.825 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.739452e-06 | 5.760 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.970647e-06 | 5.705 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.039759e-06 | 5.690 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.125575e-06 | 5.673 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.817055e-06 | 5.550 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.037850e-06 | 5.517 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.528167e-06 | 5.452 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.761862e-06 | 5.322 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.761862e-06 | 5.322 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.102948e-06 | 5.292 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.730989e-06 | 5.242 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.290360e-05 | 4.889 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.277460e-05 | 4.894 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.553141e-05 | 4.809 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.631976e-05 | 4.787 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.753949e-05 | 4.756 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.895915e-05 | 4.722 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.129790e-05 | 4.672 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.276370e-05 | 4.643 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.276370e-05 | 4.643 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.276370e-05 | 4.643 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.276370e-05 | 4.643 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.359360e-05 | 4.627 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.501318e-05 | 4.602 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.501318e-05 | 4.602 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.495718e-05 | 4.603 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.702966e-05 | 4.568 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.898491e-05 | 4.538 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.043829e-05 | 4.517 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.448577e-05 | 4.462 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.453052e-05 | 4.462 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.954892e-05 | 4.403 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.855511e-05 | 4.314 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.589993e-05 | 4.253 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.534890e-05 | 4.257 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.607188e-05 | 4.251 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.665865e-05 | 4.247 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.793246e-05 | 4.237 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.070680e-05 | 4.217 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.070680e-05 | 4.217 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.049825e-05 | 4.218 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.348928e-05 | 4.197 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.117091e-05 | 4.148 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.298966e-05 | 4.137 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.488664e-05 | 4.126 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.992509e-05 | 4.097 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.768090e-05 | 4.110 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.706405e-05 | 4.060 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.257900e-05 | 4.033 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.036878e-04 | 3.984 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.107048e-04 | 3.956 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.346285e-04 | 3.871 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.333517e-04 | 3.875 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.357787e-04 | 3.867 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.398438e-04 | 3.854 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.423321e-04 | 3.847 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.426212e-04 | 3.846 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.707698e-04 | 3.768 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.786459e-04 | 3.748 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.945420e-04 | 3.711 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.011893e-04 | 3.696 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.090852e-04 | 3.680 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.206458e-04 | 3.656 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.465050e-04 | 3.608 | 1 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.484711e-04 | 3.605 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.684870e-04 | 3.571 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.624334e-04 | 3.581 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.561085e-04 | 3.592 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.717388e-04 | 3.566 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.719295e-04 | 3.566 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.723255e-04 | 3.565 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.774529e-04 | 3.557 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.928565e-04 | 3.533 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.033363e-04 | 3.518 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.983238e-04 | 3.525 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.113702e-04 | 3.507 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.113702e-04 | 3.507 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.146428e-04 | 3.502 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.304894e-04 | 3.481 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.493347e-04 | 3.457 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.499913e-04 | 3.456 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.779916e-04 | 3.423 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.909906e-04 | 3.408 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.974888e-04 | 3.401 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.066015e-04 | 3.391 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.079790e-04 | 3.389 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.097348e-04 | 3.387 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.189988e-04 | 3.378 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.379782e-04 | 3.359 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.001409e-04 | 3.301 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.132314e-04 | 3.290 | 1 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.434883e-04 | 3.265 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.617127e-04 | 3.179 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.281156e-04 | 3.202 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.653865e-04 | 3.177 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.908736e-04 | 3.161 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.957576e-04 | 3.158 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.773932e-04 | 3.109 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.773932e-04 | 3.109 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.427529e-04 | 3.074 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.427529e-04 | 3.074 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.166614e-04 | 3.088 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.416224e-04 | 3.075 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.314867e-04 | 3.080 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.547276e-04 | 3.068 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.697858e-04 | 3.061 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.019268e-04 | 3.045 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.702261e-04 | 3.013 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 9.736584e-04 | 3.012 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.813624e-04 | 3.008 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.845151e-04 | 3.007 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.094195e-03 | 2.961 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.129092e-03 | 2.947 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.087952e-03 | 2.963 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.087952e-03 | 2.963 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.135371e-03 | 2.945 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.251936e-03 | 2.902 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.251936e-03 | 2.902 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.266363e-03 | 2.897 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.266363e-03 | 2.897 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.284877e-03 | 2.891 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.284877e-03 | 2.891 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.371899e-03 | 2.863 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.371899e-03 | 2.863 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.525612e-03 | 2.817 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.532964e-03 | 2.814 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.532964e-03 | 2.814 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.488611e-03 | 2.827 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.515496e-03 | 2.819 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.631684e-03 | 2.787 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.699230e-03 | 2.770 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.701048e-03 | 2.769 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.701048e-03 | 2.769 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.707606e-03 | 2.768 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.749420e-03 | 2.757 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.749420e-03 | 2.757 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.829327e-03 | 2.738 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.824519e-03 | 2.739 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.914239e-03 | 2.718 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.001905e-03 | 2.699 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.003861e-03 | 2.698 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.820197e-03 | 2.740 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.829327e-03 | 2.738 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.890390e-03 | 2.723 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.889628e-03 | 2.724 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.019342e-03 | 2.695 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.026869e-03 | 2.693 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.235543e-03 | 2.651 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.279633e-03 | 2.642 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.388077e-03 | 2.622 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.554671e-03 | 2.593 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.585862e-03 | 2.587 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.586428e-03 | 2.587 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.625788e-03 | 2.581 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.651426e-03 | 2.577 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.651426e-03 | 2.577 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.689392e-03 | 2.570 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.689392e-03 | 2.570 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.698481e-03 | 2.569 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.804931e-03 | 2.552 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.804931e-03 | 2.552 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.804931e-03 | 2.552 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.123813e-03 | 2.505 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.316463e-03 | 2.479 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.014776e-03 | 2.521 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.352838e-03 | 2.475 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.006302e-03 | 2.522 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.365421e-03 | 2.473 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.395431e-03 | 2.469 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.395431e-03 | 2.469 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.432418e-03 | 2.464 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.432418e-03 | 2.464 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.453893e-03 | 2.462 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.569354e-03 | 2.447 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.689135e-03 | 2.433 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.746749e-03 | 2.426 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.003035e-03 | 2.398 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.007651e-03 | 2.397 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 4.007651e-03 | 2.397 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.094965e-03 | 2.388 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.103646e-03 | 2.387 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.217717e-03 | 2.375 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.217717e-03 | 2.375 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.463607e-03 | 2.350 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.653720e-03 | 2.332 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.981996e-03 | 2.303 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.522124e-03 | 2.345 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.522124e-03 | 2.345 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.657665e-03 | 2.332 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.535497e-03 | 2.343 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.396556e-03 | 2.357 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.024447e-03 | 2.299 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.055239e-03 | 2.296 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.164204e-03 | 2.287 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.164204e-03 | 2.287 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.194304e-03 | 2.284 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.258340e-03 | 2.279 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.388231e-03 | 2.269 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.405298e-03 | 2.267 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.461101e-03 | 2.263 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.471663e-03 | 2.262 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.471663e-03 | 2.262 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.589957e-03 | 2.253 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.589957e-03 | 2.253 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.748153e-03 | 2.240 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.737818e-03 | 2.171 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.925161e-03 | 2.227 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.484560e-03 | 2.188 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.484560e-03 | 2.188 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.123021e-03 | 2.213 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.654510e-03 | 2.177 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.802973e-03 | 2.236 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.857532e-03 | 2.232 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.381258e-03 | 2.195 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.737818e-03 | 2.171 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.925161e-03 | 2.227 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.115945e-03 | 2.214 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.469933e-03 | 2.189 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.925161e-03 | 2.227 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.737818e-03 | 2.171 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.191447e-03 | 2.208 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.951240e-03 | 2.225 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.737818e-03 | 2.171 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.925161e-03 | 2.227 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.853270e-03 | 2.233 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.255033e-03 | 2.204 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.775889e-03 | 2.169 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.832109e-03 | 2.165 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.832109e-03 | 2.165 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.966053e-03 | 2.157 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.966053e-03 | 2.157 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.082500e-03 | 2.150 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.083907e-03 | 2.150 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.139075e-03 | 2.146 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.387240e-03 | 2.132 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.513493e-03 | 2.124 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.513493e-03 | 2.124 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.513493e-03 | 2.124 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.700664e-03 | 2.113 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.768849e-03 | 2.110 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.814465e-03 | 2.107 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.863918e-03 | 2.104 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.066968e-03 | 2.093 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.187151e-03 | 2.087 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 9.099170e-03 | 2.041 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 9.099170e-03 | 2.041 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 9.099170e-03 | 2.041 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 9.099170e-03 | 2.041 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.764666e-03 | 2.057 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.764666e-03 | 2.057 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.764666e-03 | 2.057 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.764666e-03 | 2.057 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.413521e-03 | 2.075 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.928061e-03 | 2.003 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.797603e-03 | 2.056 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.164113e-03 | 2.038 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.797603e-03 | 2.056 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.413521e-03 | 2.075 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.413521e-03 | 2.075 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.773159e-03 | 2.057 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.764666e-03 | 2.057 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.977576e-03 | 2.047 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.928061e-03 | 2.003 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.764666e-03 | 2.057 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 9.099170e-03 | 2.041 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.803139e-03 | 2.055 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.413521e-03 | 2.075 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.928061e-03 | 2.003 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 9.099170e-03 | 2.041 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.367484e-03 | 2.077 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.009461e-02 | 1.996 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.014673e-02 | 1.994 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.024656e-02 | 1.989 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.029220e-02 | 1.987 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.068111e-02 | 1.971 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.081953e-02 | 1.966 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.088933e-02 | 1.963 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.111499e-02 | 1.954 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.111499e-02 | 1.954 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.116435e-02 | 1.952 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.116435e-02 | 1.952 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.116435e-02 | 1.952 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.116435e-02 | 1.952 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.121701e-02 | 1.950 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.145034e-02 | 1.941 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.145034e-02 | 1.941 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.164392e-02 | 1.934 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.164392e-02 | 1.934 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.164392e-02 | 1.934 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.172418e-02 | 1.931 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.172418e-02 | 1.931 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.200876e-02 | 1.921 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.210345e-02 | 1.917 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.283290e-02 | 1.892 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.283290e-02 | 1.892 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.303105e-02 | 1.885 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.315018e-02 | 1.881 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.337227e-02 | 1.874 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.337227e-02 | 1.874 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.357712e-02 | 1.867 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.369200e-02 | 1.864 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.369200e-02 | 1.864 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.369836e-02 | 1.863 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.388921e-02 | 1.857 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.388921e-02 | 1.857 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.388921e-02 | 1.857 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.748443e-02 | 1.757 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.417815e-02 | 1.848 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.417815e-02 | 1.848 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.753535e-02 | 1.756 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.514225e-02 | 1.820 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.545292e-02 | 1.811 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.546080e-02 | 1.811 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.504922e-02 | 1.822 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.565035e-02 | 1.805 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.545292e-02 | 1.811 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.629417e-02 | 1.788 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.502666e-02 | 1.823 | 1 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.624514e-02 | 1.789 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.748443e-02 | 1.757 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.574370e-02 | 1.803 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.464680e-02 | 1.834 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.753535e-02 | 1.756 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.795663e-02 | 1.746 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.804262e-02 | 1.744 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.819076e-02 | 1.740 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.820170e-02 | 1.740 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.820170e-02 | 1.740 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.856912e-02 | 1.731 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.953853e-02 | 1.709 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.985931e-02 | 1.702 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.007169e-02 | 1.697 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.038206e-02 | 1.691 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.046443e-02 | 1.689 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.057448e-02 | 1.687 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.084050e-02 | 1.681 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.084050e-02 | 1.681 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.084050e-02 | 1.681 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.093826e-02 | 1.679 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.093826e-02 | 1.679 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.093826e-02 | 1.679 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.132547e-02 | 1.671 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.132547e-02 | 1.671 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.132547e-02 | 1.671 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.148738e-02 | 1.668 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.222142e-02 | 1.653 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.222142e-02 | 1.653 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.222142e-02 | 1.653 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.222142e-02 | 1.653 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.222142e-02 | 1.653 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.222142e-02 | 1.653 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.222142e-02 | 1.653 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.230021e-02 | 1.652 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.230021e-02 | 1.652 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.294378e-02 | 1.639 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.294378e-02 | 1.639 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.294378e-02 | 1.639 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.294378e-02 | 1.639 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.294378e-02 | 1.639 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.301512e-02 | 1.638 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.313291e-02 | 1.636 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.313291e-02 | 1.636 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.313291e-02 | 1.636 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.313291e-02 | 1.636 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.314667e-02 | 1.636 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.314667e-02 | 1.636 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.314667e-02 | 1.636 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.339044e-02 | 1.631 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.984303e-02 | 1.525 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.845164e-02 | 1.546 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.601775e-02 | 1.585 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.601775e-02 | 1.585 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.750164e-02 | 1.561 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.406075e-02 | 1.619 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.794794e-02 | 1.554 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.794794e-02 | 1.554 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.794794e-02 | 1.554 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.415827e-02 | 1.617 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.501659e-02 | 1.602 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.502982e-02 | 1.602 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.134946e-02 | 1.504 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.406075e-02 | 1.619 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.380173e-02 | 1.623 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.984303e-02 | 1.525 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.164105e-02 | 1.500 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.772029e-02 | 1.557 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.415827e-02 | 1.617 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.750164e-02 | 1.561 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.794794e-02 | 1.554 | 0 | 0 |
| Translation | R-HSA-72766 | 2.413250e-02 | 1.617 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.750164e-02 | 1.561 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.164105e-02 | 1.500 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.650852e-02 | 1.577 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.650852e-02 | 1.577 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.650852e-02 | 1.577 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.650852e-02 | 1.577 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.380173e-02 | 1.623 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.750164e-02 | 1.561 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.392659e-02 | 1.621 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.688198e-02 | 1.571 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.597757e-02 | 1.585 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.115945e-02 | 1.506 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.650852e-02 | 1.577 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.134946e-02 | 1.504 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.705813e-02 | 1.568 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.650852e-02 | 1.577 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.984303e-02 | 1.525 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.642422e-02 | 1.578 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.062391e-02 | 1.514 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.796935e-02 | 1.553 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.052561e-02 | 1.515 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.862558e-02 | 1.543 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.194305e-02 | 1.496 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.194305e-02 | 1.496 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.222377e-02 | 1.492 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.225621e-02 | 1.491 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.280038e-02 | 1.484 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.432299e-02 | 1.464 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.451252e-02 | 1.462 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.462516e-02 | 1.461 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.462516e-02 | 1.461 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.462516e-02 | 1.461 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.476538e-02 | 1.459 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.476538e-02 | 1.459 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.476538e-02 | 1.459 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.476538e-02 | 1.459 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.507921e-02 | 1.455 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.507921e-02 | 1.455 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.670679e-02 | 1.435 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.694133e-02 | 1.432 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.694133e-02 | 1.432 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.694133e-02 | 1.432 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.694133e-02 | 1.432 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.700404e-02 | 1.432 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.700404e-02 | 1.432 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.700404e-02 | 1.432 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.701409e-02 | 1.432 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.747054e-02 | 1.426 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.747054e-02 | 1.426 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.766406e-02 | 1.424 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.766406e-02 | 1.424 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.766406e-02 | 1.424 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.766406e-02 | 1.424 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.766406e-02 | 1.424 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.766406e-02 | 1.424 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 3.766406e-02 | 1.424 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 3.766406e-02 | 1.424 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.788932e-02 | 1.421 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.822053e-02 | 1.418 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.822053e-02 | 1.418 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.873659e-02 | 1.412 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.953720e-02 | 1.403 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.062006e-02 | 1.391 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.062006e-02 | 1.391 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.062006e-02 | 1.391 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.082679e-02 | 1.389 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.099667e-02 | 1.387 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.129484e-02 | 1.384 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.191727e-02 | 1.378 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.191727e-02 | 1.378 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.191727e-02 | 1.378 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.220810e-02 | 1.375 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.220810e-02 | 1.375 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.220810e-02 | 1.375 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.326170e-02 | 1.364 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.330776e-02 | 1.363 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.338778e-02 | 1.363 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.408895e-02 | 1.356 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.408895e-02 | 1.356 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.408895e-02 | 1.356 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.525931e-02 | 1.344 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.570569e-02 | 1.340 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.643821e-02 | 1.333 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.643821e-02 | 1.333 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.662930e-02 | 1.331 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.674091e-02 | 1.330 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.674091e-02 | 1.330 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.674091e-02 | 1.330 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.674091e-02 | 1.330 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.788303e-02 | 1.320 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.788303e-02 | 1.320 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.823659e-02 | 1.317 | 1 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.828700e-02 | 1.316 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.910521e-02 | 1.309 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.961398e-02 | 1.304 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.965290e-02 | 1.304 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.965290e-02 | 1.304 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.993137e-02 | 1.302 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.993137e-02 | 1.302 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.993137e-02 | 1.302 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.001324e-02 | 1.301 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.001324e-02 | 1.301 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.126880e-02 | 1.290 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.226841e-02 | 1.282 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.226841e-02 | 1.282 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.248332e-02 | 1.280 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.349424e-02 | 1.272 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 7.673562e-02 | 1.115 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.673562e-02 | 1.115 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 7.673562e-02 | 1.115 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.432641e-02 | 1.192 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.432641e-02 | 1.192 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.432641e-02 | 1.192 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.275826e-02 | 1.202 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.675615e-02 | 1.246 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.804659e-02 | 1.167 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.048790e-02 | 1.094 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.048790e-02 | 1.094 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.048790e-02 | 1.094 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.834753e-02 | 1.234 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.405236e-02 | 1.193 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.069304e-02 | 1.217 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.151877e-02 | 1.211 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.884801e-02 | 1.103 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.672885e-02 | 1.246 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.191906e-02 | 1.208 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.860034e-02 | 1.164 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.613392e-02 | 1.118 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.882334e-02 | 1.230 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.275826e-02 | 1.202 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.613392e-02 | 1.118 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.750382e-02 | 1.111 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.688468e-02 | 1.175 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.275826e-02 | 1.202 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.804659e-02 | 1.167 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.344316e-02 | 1.134 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.613392e-02 | 1.118 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.882334e-02 | 1.230 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.712654e-02 | 1.243 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.688468e-02 | 1.175 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.853067e-02 | 1.105 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.053119e-02 | 1.218 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.498380e-02 | 1.260 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.525703e-02 | 1.185 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.804659e-02 | 1.167 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.404129e-02 | 1.267 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.712654e-02 | 1.243 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.882334e-02 | 1.230 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.712654e-02 | 1.243 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.712654e-02 | 1.243 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.853067e-02 | 1.105 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.673955e-02 | 1.176 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.165107e-02 | 1.145 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.750382e-02 | 1.111 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.029622e-02 | 1.220 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.065805e-02 | 1.217 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.834753e-02 | 1.234 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.069304e-02 | 1.217 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.784601e-02 | 1.168 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.784601e-02 | 1.168 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.864082e-02 | 1.104 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.306209e-02 | 1.200 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.027072e-02 | 1.153 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.804659e-02 | 1.167 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.673955e-02 | 1.176 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.672740e-02 | 1.176 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.860034e-02 | 1.164 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.882334e-02 | 1.230 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.404129e-02 | 1.267 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.926123e-02 | 1.101 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.048790e-02 | 1.094 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.688468e-02 | 1.175 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.048790e-02 | 1.094 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.715158e-02 | 1.113 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.712654e-02 | 1.243 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.627833e-02 | 1.179 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.085237e-02 | 1.092 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.085237e-02 | 1.092 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.292020e-02 | 1.081 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.292020e-02 | 1.081 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.292020e-02 | 1.081 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.348215e-02 | 1.078 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.413089e-02 | 1.075 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 8.448954e-02 | 1.073 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.518176e-02 | 1.070 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.518176e-02 | 1.070 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.518176e-02 | 1.070 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.572491e-02 | 1.067 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.609416e-02 | 1.065 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.609416e-02 | 1.065 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.051309e-02 | 1.043 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.079678e-02 | 1.042 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.330526e-02 | 1.030 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 9.379581e-02 | 1.028 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 9.379581e-02 | 1.028 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 9.379581e-02 | 1.028 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.405381e-02 | 1.027 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.405381e-02 | 1.027 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.405381e-02 | 1.027 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.675924e-02 | 1.014 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.000246e-01 | 1.000 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.000246e-01 | 1.000 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.003558e-01 | 0.998 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.003558e-01 | 0.998 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.015377e-01 | 0.993 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.015377e-01 | 0.993 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.015377e-01 | 0.993 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.015377e-01 | 0.993 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.031901e-01 | 0.986 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.031901e-01 | 0.986 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.069732e-01 | 0.971 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.069732e-01 | 0.971 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.069732e-01 | 0.971 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.069732e-01 | 0.971 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.074270e-01 | 0.969 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.081181e-01 | 0.966 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.082348e-01 | 0.966 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.094685e-01 | 0.961 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.112253e-01 | 0.954 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.115291e-01 | 0.953 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.115291e-01 | 0.953 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.115701e-01 | 0.952 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.115701e-01 | 0.952 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.115701e-01 | 0.952 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.115701e-01 | 0.952 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.125769e-01 | 0.949 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.164172e-01 | 0.934 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.164172e-01 | 0.934 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.201549e-01 | 0.920 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.201549e-01 | 0.920 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.202765e-01 | 0.920 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.203278e-01 | 0.920 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.203278e-01 | 0.920 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.203278e-01 | 0.920 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.215242e-01 | 0.915 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.215242e-01 | 0.915 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.220823e-01 | 0.913 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.232258e-01 | 0.909 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.243940e-01 | 0.905 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.243940e-01 | 0.905 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.257909e-01 | 0.900 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.258837e-01 | 0.900 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.301032e-01 | 0.886 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.304474e-01 | 0.885 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.304474e-01 | 0.885 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.307104e-01 | 0.884 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.307104e-01 | 0.884 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.307104e-01 | 0.884 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.314923e-01 | 0.881 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.320759e-01 | 0.879 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.328494e-01 | 0.877 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.349812e-01 | 0.870 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.372828e-01 | 0.862 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.372828e-01 | 0.862 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.386548e-01 | 0.858 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.388165e-01 | 0.858 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.410596e-01 | 0.851 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.410596e-01 | 0.851 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 1.410596e-01 | 0.851 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.033190e-01 | 0.692 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.033190e-01 | 0.692 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.033190e-01 | 0.692 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.033190e-01 | 0.692 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.033190e-01 | 0.692 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 2.033190e-01 | 0.692 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.033190e-01 | 0.692 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.495042e-01 | 0.825 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.495042e-01 | 0.825 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.495042e-01 | 0.825 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.895766e-01 | 0.722 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.895766e-01 | 0.722 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.895766e-01 | 0.722 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.895766e-01 | 0.722 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.308581e-01 | 0.637 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.308581e-01 | 0.637 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.854404e-01 | 0.732 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.854404e-01 | 0.732 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.854404e-01 | 0.732 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.726270e-01 | 0.564 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.726270e-01 | 0.564 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.726270e-01 | 0.564 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.725940e-01 | 0.763 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.950688e-01 | 0.710 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.439687e-01 | 0.613 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 2.439687e-01 | 0.613 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.439687e-01 | 0.613 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.439687e-01 | 0.613 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.770482e-01 | 0.752 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.183792e-01 | 0.661 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.607652e-01 | 0.794 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.742585e-01 | 0.562 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.742585e-01 | 0.562 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.742585e-01 | 0.562 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.742585e-01 | 0.562 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.742585e-01 | 0.562 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.742585e-01 | 0.562 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.742585e-01 | 0.562 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.769646e-01 | 0.752 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.769646e-01 | 0.752 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.423839e-01 | 0.615 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.423839e-01 | 0.615 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.937917e-01 | 0.713 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.937917e-01 | 0.713 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.937917e-01 | 0.713 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.746181e-01 | 0.758 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.669435e-01 | 0.574 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.365032e-01 | 0.626 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.668614e-01 | 0.778 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.291126e-01 | 0.640 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.291126e-01 | 0.640 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.574458e-01 | 0.589 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.627520e-01 | 0.788 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.835292e-01 | 0.736 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.473040e-01 | 0.607 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.853983e-01 | 0.545 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.461774e-01 | 0.835 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.434123e-01 | 0.614 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.896650e-01 | 0.722 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.291126e-01 | 0.640 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.452535e-01 | 0.838 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 2.544764e-01 | 0.594 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.895766e-01 | 0.722 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.700916e-01 | 0.568 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.439687e-01 | 0.613 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.917058e-01 | 0.717 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.854404e-01 | 0.732 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.142744e-01 | 0.669 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.725940e-01 | 0.763 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.432172e-01 | 0.844 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.432172e-01 | 0.844 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.666716e-01 | 0.778 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 1.895766e-01 | 0.722 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.510954e-01 | 0.821 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.726270e-01 | 0.564 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.726270e-01 | 0.564 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 2.439687e-01 | 0.613 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.853983e-01 | 0.545 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.716276e-01 | 0.566 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.607652e-01 | 0.794 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.474928e-01 | 0.606 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.183792e-01 | 0.661 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.742585e-01 | 0.562 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.742585e-01 | 0.562 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.746181e-01 | 0.758 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.950688e-01 | 0.710 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.792390e-01 | 0.747 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.892778e-01 | 0.723 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 2.742585e-01 | 0.562 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.574458e-01 | 0.589 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.710670e-01 | 0.767 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.330365e-01 | 0.633 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 2.033190e-01 | 0.692 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.895766e-01 | 0.722 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.854404e-01 | 0.732 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.669435e-01 | 0.574 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.781296e-01 | 0.749 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.432172e-01 | 0.844 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.793301e-01 | 0.746 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.121838e-01 | 0.673 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.515628e-01 | 0.599 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.163697e-01 | 0.665 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 1.607652e-01 | 0.794 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.607652e-01 | 0.794 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.669435e-01 | 0.574 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.510954e-01 | 0.821 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.160656e-01 | 0.665 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.853594e-01 | 0.732 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.896650e-01 | 0.722 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.922041e-01 | 0.716 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.586356e-01 | 0.800 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.770482e-01 | 0.752 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.812351e-01 | 0.742 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.111930e-01 | 0.675 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.669435e-01 | 0.574 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.528316e-01 | 0.816 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.725940e-01 | 0.763 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.473040e-01 | 0.607 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.128110e-01 | 0.672 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.775318e-01 | 0.557 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.566490e-01 | 0.805 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.033190e-01 | 0.692 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.033190e-01 | 0.692 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.586356e-01 | 0.800 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.950688e-01 | 0.710 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.423839e-01 | 0.615 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.111930e-01 | 0.675 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 2.574458e-01 | 0.589 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.575964e-01 | 0.802 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.048043e-01 | 0.689 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.770482e-01 | 0.752 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.853983e-01 | 0.545 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.784761e-01 | 0.555 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.510954e-01 | 0.821 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.624559e-01 | 0.789 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.574458e-01 | 0.589 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.473040e-01 | 0.607 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.142744e-01 | 0.669 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.937917e-01 | 0.713 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.111930e-01 | 0.675 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.043419e-01 | 0.690 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.474928e-01 | 0.606 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.967377e-01 | 0.706 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.285213e-01 | 0.641 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.710670e-01 | 0.767 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.980420e-01 | 0.703 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.635994e-01 | 0.579 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.542449e-01 | 0.812 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.308581e-01 | 0.637 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.510954e-01 | 0.821 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.726270e-01 | 0.564 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.601108e-01 | 0.796 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.662745e-01 | 0.575 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.853983e-01 | 0.545 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.978749e-01 | 0.704 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.364583e-01 | 0.626 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.743448e-01 | 0.759 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.663482e-01 | 0.779 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.495042e-01 | 0.825 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.577483e-01 | 0.802 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.308581e-01 | 0.637 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.854404e-01 | 0.732 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.726270e-01 | 0.564 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.512052e-01 | 0.820 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.281658e-01 | 0.642 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.962190e-01 | 0.707 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.420576e-01 | 0.616 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.788074e-01 | 0.555 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.854404e-01 | 0.732 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.203251e-01 | 0.657 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.853983e-01 | 0.545 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 1.769646e-01 | 0.752 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.491065e-01 | 0.827 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.588146e-01 | 0.587 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.792390e-01 | 0.747 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.104251e-01 | 0.677 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.716276e-01 | 0.566 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.574458e-01 | 0.589 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.574458e-01 | 0.589 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.365032e-01 | 0.626 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.510954e-01 | 0.821 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.769646e-01 | 0.752 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.962190e-01 | 0.707 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.769646e-01 | 0.752 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.548177e-01 | 0.810 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.183792e-01 | 0.661 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.564706e-01 | 0.806 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.809571e-01 | 0.551 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.111930e-01 | 0.675 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.548177e-01 | 0.810 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.548177e-01 | 0.810 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.745429e-01 | 0.561 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.816846e-01 | 0.741 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.473040e-01 | 0.607 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.642804e-01 | 0.578 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.950688e-01 | 0.710 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.594347e-01 | 0.586 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.888314e-01 | 0.539 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.889141e-01 | 0.539 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.889141e-01 | 0.539 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.889141e-01 | 0.539 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.889141e-01 | 0.539 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.889141e-01 | 0.539 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.889141e-01 | 0.539 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.889141e-01 | 0.539 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.889141e-01 | 0.539 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.890712e-01 | 0.539 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.890712e-01 | 0.539 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.890712e-01 | 0.539 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.890712e-01 | 0.539 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.890712e-01 | 0.539 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.909684e-01 | 0.536 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.916755e-01 | 0.535 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.919218e-01 | 0.535 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.919218e-01 | 0.535 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.919218e-01 | 0.535 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.919218e-01 | 0.535 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.005025e-01 | 0.522 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.048047e-01 | 0.516 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.048987e-01 | 0.516 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.048987e-01 | 0.516 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.048987e-01 | 0.516 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.073124e-01 | 0.512 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.073124e-01 | 0.512 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.143024e-01 | 0.503 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.143024e-01 | 0.503 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.143024e-01 | 0.503 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.143024e-01 | 0.503 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.143024e-01 | 0.503 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.143024e-01 | 0.503 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.143024e-01 | 0.503 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.143024e-01 | 0.503 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.143024e-01 | 0.503 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.143024e-01 | 0.503 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.143024e-01 | 0.503 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.143024e-01 | 0.503 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.171883e-01 | 0.499 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.224477e-01 | 0.492 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.224477e-01 | 0.492 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.224477e-01 | 0.492 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.224477e-01 | 0.492 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.244348e-01 | 0.489 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.246587e-01 | 0.489 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.282038e-01 | 0.484 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.426184e-01 | 0.465 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.426184e-01 | 0.465 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.426184e-01 | 0.465 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.426184e-01 | 0.465 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.426184e-01 | 0.465 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.427144e-01 | 0.465 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.442304e-01 | 0.463 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.442304e-01 | 0.463 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.445618e-01 | 0.463 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.445618e-01 | 0.463 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.445618e-01 | 0.463 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.461579e-01 | 0.461 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.507891e-01 | 0.455 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.551573e-01 | 0.450 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.554226e-01 | 0.449 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.554226e-01 | 0.449 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.554226e-01 | 0.449 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.554226e-01 | 0.449 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.554226e-01 | 0.449 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.554226e-01 | 0.449 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.554226e-01 | 0.449 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.554226e-01 | 0.449 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.554226e-01 | 0.449 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.554226e-01 | 0.449 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.554226e-01 | 0.449 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.554226e-01 | 0.449 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.596815e-01 | 0.444 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.608869e-01 | 0.443 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.641350e-01 | 0.439 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.653173e-01 | 0.437 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.653173e-01 | 0.437 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.653173e-01 | 0.437 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.653173e-01 | 0.437 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.653173e-01 | 0.437 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.653173e-01 | 0.437 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.653173e-01 | 0.437 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.653173e-01 | 0.437 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 3.653173e-01 | 0.437 | 0 | 0 |
| Glycogen storage disease type 0 (liver GYS2) | R-HSA-3858516 | 3.653173e-01 | 0.437 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.653173e-01 | 0.437 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.653173e-01 | 0.437 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.653173e-01 | 0.437 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.653173e-01 | 0.437 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.653173e-01 | 0.437 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.653173e-01 | 0.437 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.653173e-01 | 0.437 | 0 | 0 |
| Antagonism of Activin by Follistatin | R-HSA-2473224 | 3.653173e-01 | 0.437 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.653173e-01 | 0.437 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.653173e-01 | 0.437 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.663589e-01 | 0.436 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.663589e-01 | 0.436 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.663589e-01 | 0.436 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.663589e-01 | 0.436 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 3.663589e-01 | 0.436 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.663589e-01 | 0.436 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 3.663589e-01 | 0.436 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.667664e-01 | 0.436 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.667664e-01 | 0.436 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.667664e-01 | 0.436 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.667664e-01 | 0.436 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.680952e-01 | 0.434 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.680952e-01 | 0.434 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.680952e-01 | 0.434 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.687661e-01 | 0.433 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.692611e-01 | 0.433 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.721644e-01 | 0.429 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.803512e-01 | 0.420 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.852777e-01 | 0.414 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.852777e-01 | 0.414 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 3.885505e-01 | 0.411 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.885505e-01 | 0.411 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.885505e-01 | 0.411 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.889871e-01 | 0.410 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.889871e-01 | 0.410 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.889871e-01 | 0.410 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.889871e-01 | 0.410 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.935098e-01 | 0.405 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.935098e-01 | 0.405 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.935098e-01 | 0.405 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 3.935098e-01 | 0.405 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.935098e-01 | 0.405 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.946600e-01 | 0.404 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.956261e-01 | 0.403 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.956261e-01 | 0.403 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.956261e-01 | 0.403 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.956261e-01 | 0.403 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.956261e-01 | 0.403 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.956261e-01 | 0.403 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.956261e-01 | 0.403 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.956261e-01 | 0.403 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 3.956261e-01 | 0.403 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.956261e-01 | 0.403 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.956261e-01 | 0.403 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.967990e-01 | 0.401 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.967990e-01 | 0.401 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.967990e-01 | 0.401 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.967990e-01 | 0.401 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.967990e-01 | 0.401 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.974137e-01 | 0.401 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.974137e-01 | 0.401 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.974137e-01 | 0.401 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.974137e-01 | 0.401 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.974137e-01 | 0.401 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.011631e-01 | 0.397 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.018100e-01 | 0.396 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.075229e-01 | 0.390 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.111531e-01 | 0.386 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.111531e-01 | 0.386 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.151494e-01 | 0.382 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.151494e-01 | 0.382 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.164429e-01 | 0.380 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.170599e-01 | 0.380 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.170599e-01 | 0.380 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.170599e-01 | 0.380 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.187615e-01 | 0.378 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.187615e-01 | 0.378 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.187615e-01 | 0.378 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.187615e-01 | 0.378 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.239647e-01 | 0.373 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.239647e-01 | 0.373 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.250895e-01 | 0.372 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 4.268293e-01 | 0.370 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.268293e-01 | 0.370 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.329423e-01 | 0.364 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.331982e-01 | 0.363 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.331982e-01 | 0.363 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.335154e-01 | 0.363 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.335154e-01 | 0.363 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.335154e-01 | 0.363 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.335154e-01 | 0.363 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 4.335154e-01 | 0.363 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.335154e-01 | 0.363 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.335154e-01 | 0.363 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.335154e-01 | 0.363 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.335154e-01 | 0.363 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.335154e-01 | 0.363 | 0 | 0 |
| NGF processing | R-HSA-167060 | 4.335154e-01 | 0.363 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 4.335154e-01 | 0.363 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.339152e-01 | 0.363 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.346352e-01 | 0.362 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.346352e-01 | 0.362 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.346352e-01 | 0.362 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.346352e-01 | 0.362 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.346352e-01 | 0.362 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.393276e-01 | 0.357 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.436935e-01 | 0.353 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.507248e-01 | 0.346 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.511678e-01 | 0.346 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.520615e-01 | 0.345 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.550606e-01 | 0.342 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.563144e-01 | 0.341 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.563144e-01 | 0.341 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.582314e-01 | 0.339 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.634498e-01 | 0.334 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.634498e-01 | 0.334 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.683691e-01 | 0.329 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.683691e-01 | 0.329 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.683691e-01 | 0.329 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.700911e-01 | 0.328 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.722427e-01 | 0.326 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.722427e-01 | 0.326 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.722427e-01 | 0.326 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.722427e-01 | 0.326 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.722427e-01 | 0.326 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.722427e-01 | 0.326 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.722427e-01 | 0.326 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.766831e-01 | 0.322 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.829365e-01 | 0.316 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.851387e-01 | 0.314 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 4.851387e-01 | 0.314 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 4.851387e-01 | 0.314 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 4.851387e-01 | 0.314 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.851387e-01 | 0.314 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.879710e-01 | 0.312 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.893436e-01 | 0.310 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.921947e-01 | 0.308 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.926677e-01 | 0.307 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.926677e-01 | 0.307 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.928434e-01 | 0.307 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.943890e-01 | 0.306 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.943890e-01 | 0.306 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.943890e-01 | 0.306 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.943890e-01 | 0.306 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.943890e-01 | 0.306 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.943890e-01 | 0.306 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.943890e-01 | 0.306 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.943890e-01 | 0.306 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.943890e-01 | 0.306 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.943890e-01 | 0.306 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 4.943890e-01 | 0.306 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.980136e-01 | 0.303 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.980136e-01 | 0.303 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.021991e-01 | 0.299 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.069950e-01 | 0.295 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.082994e-01 | 0.294 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.082994e-01 | 0.294 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.082994e-01 | 0.294 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.082994e-01 | 0.294 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.082994e-01 | 0.294 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.082994e-01 | 0.294 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.132057e-01 | 0.290 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.132057e-01 | 0.290 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.132057e-01 | 0.290 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.132057e-01 | 0.290 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.164398e-01 | 0.287 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.164398e-01 | 0.287 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.212012e-01 | 0.283 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.259508e-01 | 0.279 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.348639e-01 | 0.272 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.396784e-01 | 0.268 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.399095e-01 | 0.268 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.399095e-01 | 0.268 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.404361e-01 | 0.267 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.404361e-01 | 0.267 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.404361e-01 | 0.267 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.404361e-01 | 0.267 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.417405e-01 | 0.266 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.427044e-01 | 0.265 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.427044e-01 | 0.265 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.427044e-01 | 0.265 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.427044e-01 | 0.265 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.465066e-01 | 0.262 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.465066e-01 | 0.262 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.487243e-01 | 0.261 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.487243e-01 | 0.261 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.487243e-01 | 0.261 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.487243e-01 | 0.261 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.487243e-01 | 0.261 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.487243e-01 | 0.261 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.487243e-01 | 0.261 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.487243e-01 | 0.261 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.487243e-01 | 0.261 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.487243e-01 | 0.261 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.487243e-01 | 0.261 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.566914e-01 | 0.254 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.572893e-01 | 0.254 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.572893e-01 | 0.254 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.576468e-01 | 0.254 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.582937e-01 | 0.253 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.623346e-01 | 0.250 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.623346e-01 | 0.250 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.623346e-01 | 0.250 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.667666e-01 | 0.247 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.667666e-01 | 0.247 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.694920e-01 | 0.245 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.751645e-01 | 0.240 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.753962e-01 | 0.240 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.753962e-01 | 0.240 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.753962e-01 | 0.240 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.753962e-01 | 0.240 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.753962e-01 | 0.240 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.753962e-01 | 0.240 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.763265e-01 | 0.239 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.763265e-01 | 0.239 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 5.763265e-01 | 0.239 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.795361e-01 | 0.237 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.803235e-01 | 0.236 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.808186e-01 | 0.236 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.808186e-01 | 0.236 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.824097e-01 | 0.235 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.833055e-01 | 0.234 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.843672e-01 | 0.233 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.905121e-01 | 0.229 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.927870e-01 | 0.227 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.972234e-01 | 0.224 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.972234e-01 | 0.224 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.972234e-01 | 0.224 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.972234e-01 | 0.224 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.972234e-01 | 0.224 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.972234e-01 | 0.224 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.972234e-01 | 0.224 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.972234e-01 | 0.224 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.972234e-01 | 0.224 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.972234e-01 | 0.224 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.972234e-01 | 0.224 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.972234e-01 | 0.224 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.972234e-01 | 0.224 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.972234e-01 | 0.224 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.972234e-01 | 0.224 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.972234e-01 | 0.224 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.972234e-01 | 0.224 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.972234e-01 | 0.224 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.972234e-01 | 0.224 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.972234e-01 | 0.224 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.972234e-01 | 0.224 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.972234e-01 | 0.224 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.972234e-01 | 0.224 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.987885e-01 | 0.223 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.987885e-01 | 0.223 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.987885e-01 | 0.223 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.055780e-01 | 0.218 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.063458e-01 | 0.217 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.063458e-01 | 0.217 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.063458e-01 | 0.217 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.086202e-01 | 0.216 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.107330e-01 | 0.214 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.134997e-01 | 0.212 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.165464e-01 | 0.210 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.165464e-01 | 0.210 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.172681e-01 | 0.210 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.175338e-01 | 0.209 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.175338e-01 | 0.209 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.175338e-01 | 0.209 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.196120e-01 | 0.208 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.223303e-01 | 0.206 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.264326e-01 | 0.203 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.281181e-01 | 0.202 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.323917e-01 | 0.199 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.355500e-01 | 0.197 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.355500e-01 | 0.197 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.355500e-01 | 0.197 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.355500e-01 | 0.197 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.355500e-01 | 0.197 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.357516e-01 | 0.197 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.399359e-01 | 0.194 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.405128e-01 | 0.193 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.405128e-01 | 0.193 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.405128e-01 | 0.193 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.405128e-01 | 0.193 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.405128e-01 | 0.193 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.405128e-01 | 0.193 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.405128e-01 | 0.193 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.405128e-01 | 0.193 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.405128e-01 | 0.193 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.405128e-01 | 0.193 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.405128e-01 | 0.193 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.405128e-01 | 0.193 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.405128e-01 | 0.193 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.405128e-01 | 0.193 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.405128e-01 | 0.193 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.405128e-01 | 0.193 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.443551e-01 | 0.191 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.464172e-01 | 0.189 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.527338e-01 | 0.185 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.534251e-01 | 0.185 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.549000e-01 | 0.184 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.591968e-01 | 0.181 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.623036e-01 | 0.179 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.623036e-01 | 0.179 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.630265e-01 | 0.178 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.630265e-01 | 0.178 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.630265e-01 | 0.178 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.656811e-01 | 0.177 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.673748e-01 | 0.176 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.777407e-01 | 0.169 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.791518e-01 | 0.168 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.791518e-01 | 0.168 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.791518e-01 | 0.168 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.791518e-01 | 0.168 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.791518e-01 | 0.168 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.791518e-01 | 0.168 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.791518e-01 | 0.168 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.791518e-01 | 0.168 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.791518e-01 | 0.168 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.791518e-01 | 0.168 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.791518e-01 | 0.168 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.791518e-01 | 0.168 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.836447e-01 | 0.165 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.836447e-01 | 0.165 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.836447e-01 | 0.165 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.836447e-01 | 0.165 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.836447e-01 | 0.165 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.836447e-01 | 0.165 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.842144e-01 | 0.165 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.842144e-01 | 0.165 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.879199e-01 | 0.162 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.887422e-01 | 0.162 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.888092e-01 | 0.162 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.888092e-01 | 0.162 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.888092e-01 | 0.162 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 6.888092e-01 | 0.162 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.888092e-01 | 0.162 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.888092e-01 | 0.162 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.899907e-01 | 0.161 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.919936e-01 | 0.160 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.928020e-01 | 0.159 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.960641e-01 | 0.157 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.020121e-01 | 0.154 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.020121e-01 | 0.154 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.039625e-01 | 0.152 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.049935e-01 | 0.152 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.053265e-01 | 0.152 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.129448e-01 | 0.147 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.129448e-01 | 0.147 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.129448e-01 | 0.147 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.129448e-01 | 0.147 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.129448e-01 | 0.147 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.136398e-01 | 0.147 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.136398e-01 | 0.147 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.136398e-01 | 0.147 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.136398e-01 | 0.147 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.136398e-01 | 0.147 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.136398e-01 | 0.147 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.136398e-01 | 0.147 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.136398e-01 | 0.147 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.136398e-01 | 0.147 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.136398e-01 | 0.147 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.136398e-01 | 0.147 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.184667e-01 | 0.144 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.197171e-01 | 0.143 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.232669e-01 | 0.141 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.232669e-01 | 0.141 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.332887e-01 | 0.135 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.332971e-01 | 0.135 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.354893e-01 | 0.133 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.354893e-01 | 0.133 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.354893e-01 | 0.133 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.354893e-01 | 0.133 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.354893e-01 | 0.133 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.354893e-01 | 0.133 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.354893e-01 | 0.133 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.415735e-01 | 0.130 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.415735e-01 | 0.130 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.444225e-01 | 0.128 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.444225e-01 | 0.128 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.444225e-01 | 0.128 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.444225e-01 | 0.128 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.444225e-01 | 0.128 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.444225e-01 | 0.128 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.444225e-01 | 0.128 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.444225e-01 | 0.128 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.444225e-01 | 0.128 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.444225e-01 | 0.128 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.444225e-01 | 0.128 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.444225e-01 | 0.128 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.444225e-01 | 0.128 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.444225e-01 | 0.128 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.464987e-01 | 0.127 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.464987e-01 | 0.127 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 7.469158e-01 | 0.127 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.482498e-01 | 0.126 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.565060e-01 | 0.121 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.565060e-01 | 0.121 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.586628e-01 | 0.120 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.587575e-01 | 0.120 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.589030e-01 | 0.120 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.679061e-01 | 0.115 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.713809e-01 | 0.113 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.713809e-01 | 0.113 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.718977e-01 | 0.112 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.718977e-01 | 0.112 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.718977e-01 | 0.112 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.718977e-01 | 0.112 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.718977e-01 | 0.112 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.718977e-01 | 0.112 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.718977e-01 | 0.112 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.718977e-01 | 0.112 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.718977e-01 | 0.112 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.718977e-01 | 0.112 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.718977e-01 | 0.112 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.732406e-01 | 0.112 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.752797e-01 | 0.111 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.758029e-01 | 0.110 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.760626e-01 | 0.110 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.760626e-01 | 0.110 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.760626e-01 | 0.110 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.779590e-01 | 0.109 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.800689e-01 | 0.108 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.800689e-01 | 0.108 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.800689e-01 | 0.108 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.812287e-01 | 0.107 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.815815e-01 | 0.107 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.868655e-01 | 0.104 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.903461e-01 | 0.102 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.906469e-01 | 0.102 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.907314e-01 | 0.102 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.942302e-01 | 0.100 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.942302e-01 | 0.100 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.942302e-01 | 0.100 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.942302e-01 | 0.100 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.942302e-01 | 0.100 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.943918e-01 | 0.100 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.964207e-01 | 0.099 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.964207e-01 | 0.099 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.964207e-01 | 0.099 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.964207e-01 | 0.099 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 7.964207e-01 | 0.099 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.964207e-01 | 0.099 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 7.964207e-01 | 0.099 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.964207e-01 | 0.099 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.964207e-01 | 0.099 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.964207e-01 | 0.099 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.964207e-01 | 0.099 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.964207e-01 | 0.099 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.964207e-01 | 0.099 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.964207e-01 | 0.099 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.052884e-01 | 0.094 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.063759e-01 | 0.093 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.063759e-01 | 0.093 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.063759e-01 | 0.093 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.063759e-01 | 0.093 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.087479e-01 | 0.092 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.097506e-01 | 0.092 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.108163e-01 | 0.091 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.110813e-01 | 0.091 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.110813e-01 | 0.091 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.110813e-01 | 0.091 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.110813e-01 | 0.091 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.119559e-01 | 0.090 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.172064e-01 | 0.088 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.183086e-01 | 0.087 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.183086e-01 | 0.087 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.183086e-01 | 0.087 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.183086e-01 | 0.087 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.183086e-01 | 0.087 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.183086e-01 | 0.087 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.185370e-01 | 0.087 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.189828e-01 | 0.087 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.255096e-01 | 0.083 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.255096e-01 | 0.083 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.260332e-01 | 0.083 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.266890e-01 | 0.083 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.279144e-01 | 0.082 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.300619e-01 | 0.081 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.318483e-01 | 0.080 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.336050e-01 | 0.079 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.350089e-01 | 0.078 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.358738e-01 | 0.078 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.378444e-01 | 0.077 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.378444e-01 | 0.077 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.378444e-01 | 0.077 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.378444e-01 | 0.077 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.378444e-01 | 0.077 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.378444e-01 | 0.077 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 8.378444e-01 | 0.077 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.378444e-01 | 0.077 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.378444e-01 | 0.077 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.378444e-01 | 0.077 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.378444e-01 | 0.077 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.378444e-01 | 0.077 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.378444e-01 | 0.077 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.378444e-01 | 0.077 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.378444e-01 | 0.077 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.411257e-01 | 0.075 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.411257e-01 | 0.075 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.411257e-01 | 0.075 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.411257e-01 | 0.075 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.413646e-01 | 0.075 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.439195e-01 | 0.074 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.439195e-01 | 0.074 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.441306e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.512850e-01 | 0.070 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.544628e-01 | 0.068 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.544628e-01 | 0.068 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.544628e-01 | 0.068 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.544628e-01 | 0.068 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.552806e-01 | 0.068 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.552806e-01 | 0.068 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.552806e-01 | 0.068 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.552806e-01 | 0.068 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.552806e-01 | 0.068 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.552806e-01 | 0.068 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.563881e-01 | 0.067 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.619887e-01 | 0.064 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.658198e-01 | 0.063 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.658198e-01 | 0.063 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.658198e-01 | 0.063 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.658198e-01 | 0.063 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.658198e-01 | 0.063 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.658198e-01 | 0.063 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.667698e-01 | 0.062 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.667698e-01 | 0.062 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.667698e-01 | 0.062 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.708429e-01 | 0.060 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.708429e-01 | 0.060 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.708429e-01 | 0.060 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.708429e-01 | 0.060 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.708429e-01 | 0.060 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.708429e-01 | 0.060 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.708429e-01 | 0.060 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.708429e-01 | 0.060 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.708429e-01 | 0.060 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.708429e-01 | 0.060 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.708429e-01 | 0.060 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.708429e-01 | 0.060 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.708429e-01 | 0.060 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.708429e-01 | 0.060 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.732120e-01 | 0.059 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.757195e-01 | 0.058 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.765598e-01 | 0.057 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.765598e-01 | 0.057 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.775862e-01 | 0.057 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.781139e-01 | 0.056 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.781139e-01 | 0.056 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.781139e-01 | 0.056 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.781139e-01 | 0.056 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.781139e-01 | 0.056 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.788782e-01 | 0.056 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.788782e-01 | 0.056 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.841993e-01 | 0.053 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.841993e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.847325e-01 | 0.053 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.847325e-01 | 0.053 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.847325e-01 | 0.053 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.847325e-01 | 0.053 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.847325e-01 | 0.053 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.847325e-01 | 0.053 | 1 | 1 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.849656e-01 | 0.053 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.849656e-01 | 0.053 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.885598e-01 | 0.051 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.885598e-01 | 0.051 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.885598e-01 | 0.051 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.918284e-01 | 0.050 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.935925e-01 | 0.049 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.960580e-01 | 0.048 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.965210e-01 | 0.047 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.971292e-01 | 0.047 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.971292e-01 | 0.047 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.971292e-01 | 0.047 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.971292e-01 | 0.047 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.971292e-01 | 0.047 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.971292e-01 | 0.047 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.971292e-01 | 0.047 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.971292e-01 | 0.047 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.971292e-01 | 0.047 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.971292e-01 | 0.047 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.981695e-01 | 0.047 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.981695e-01 | 0.047 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.076274e-01 | 0.042 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.081932e-01 | 0.042 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.081932e-01 | 0.042 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.081932e-01 | 0.042 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.081932e-01 | 0.042 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.081932e-01 | 0.042 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.081932e-01 | 0.042 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.081932e-01 | 0.042 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.081932e-01 | 0.042 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.081932e-01 | 0.042 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.087260e-01 | 0.042 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.091222e-01 | 0.041 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.091222e-01 | 0.041 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.132479e-01 | 0.039 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.132479e-01 | 0.039 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.141754e-01 | 0.039 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.160110e-01 | 0.038 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.160895e-01 | 0.038 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.160895e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.179500e-01 | 0.037 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.180679e-01 | 0.037 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.180679e-01 | 0.037 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.180679e-01 | 0.037 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.180679e-01 | 0.037 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.180679e-01 | 0.037 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.182278e-01 | 0.037 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.220095e-01 | 0.035 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.225562e-01 | 0.035 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.225665e-01 | 0.035 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.225665e-01 | 0.035 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.225665e-01 | 0.035 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.271196e-01 | 0.033 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.272228e-01 | 0.033 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.288229e-01 | 0.032 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.293808e-01 | 0.032 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.302325e-01 | 0.031 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.317090e-01 | 0.031 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.317878e-01 | 0.031 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.347466e-01 | 0.029 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.347466e-01 | 0.029 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.347466e-01 | 0.029 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.347466e-01 | 0.029 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.347466e-01 | 0.029 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.347466e-01 | 0.029 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.356337e-01 | 0.029 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.386919e-01 | 0.027 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.386919e-01 | 0.027 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.401210e-01 | 0.027 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.412312e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.413591e-01 | 0.026 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.413591e-01 | 0.026 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.413591e-01 | 0.026 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.417664e-01 | 0.026 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.417664e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.417664e-01 | 0.026 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.417664e-01 | 0.026 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.417664e-01 | 0.026 | 1 | 1 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.419875e-01 | 0.026 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.419875e-01 | 0.026 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.419875e-01 | 0.026 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.431992e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.441439e-01 | 0.025 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.465981e-01 | 0.024 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.465981e-01 | 0.024 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.465981e-01 | 0.024 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.480315e-01 | 0.023 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.480315e-01 | 0.023 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.480315e-01 | 0.023 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.480315e-01 | 0.023 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.480315e-01 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.480315e-01 | 0.023 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.485882e-01 | 0.023 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.494675e-01 | 0.023 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.513889e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.513889e-01 | 0.022 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.513889e-01 | 0.022 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.536228e-01 | 0.021 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.536228e-01 | 0.021 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.536228e-01 | 0.021 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.566316e-01 | 0.019 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.566316e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.566316e-01 | 0.019 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.586129e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.586129e-01 | 0.018 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.586129e-01 | 0.018 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.586129e-01 | 0.018 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.586129e-01 | 0.018 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.586129e-01 | 0.018 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.597668e-01 | 0.018 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.608770e-01 | 0.017 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.630663e-01 | 0.016 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.630663e-01 | 0.016 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.630663e-01 | 0.016 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.630663e-01 | 0.016 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.630663e-01 | 0.016 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.630663e-01 | 0.016 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.630663e-01 | 0.016 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.632682e-01 | 0.016 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.634180e-01 | 0.016 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.670407e-01 | 0.015 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.670407e-01 | 0.015 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.670407e-01 | 0.015 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.673537e-01 | 0.014 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.690319e-01 | 0.014 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.697879e-01 | 0.013 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.705877e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.705877e-01 | 0.013 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.705877e-01 | 0.013 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.705877e-01 | 0.013 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.737531e-01 | 0.012 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.757743e-01 | 0.011 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.765780e-01 | 0.010 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.765780e-01 | 0.010 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.765780e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.765780e-01 | 0.010 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.765780e-01 | 0.010 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.771027e-01 | 0.010 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.773403e-01 | 0.010 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.773403e-01 | 0.010 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.773403e-01 | 0.010 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.775371e-01 | 0.010 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.779294e-01 | 0.010 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.786614e-01 | 0.009 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.790991e-01 | 0.009 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.790991e-01 | 0.009 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.790991e-01 | 0.009 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.813489e-01 | 0.008 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.813489e-01 | 0.008 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.813771e-01 | 0.008 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.824773e-01 | 0.008 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.831639e-01 | 0.007 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.833566e-01 | 0.007 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.833566e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.861169e-01 | 0.006 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.867473e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.874182e-01 | 0.005 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.879656e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.879656e-01 | 0.005 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.886003e-01 | 0.005 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.894475e-01 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.905838e-01 | 0.004 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.905838e-01 | 0.004 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.906485e-01 | 0.004 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.906485e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.908299e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.915978e-01 | 0.004 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.930634e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.931439e-01 | 0.003 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.933101e-01 | 0.003 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.933101e-01 | 0.003 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.933101e-01 | 0.003 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.933101e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.933101e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.937428e-01 | 0.003 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.937428e-01 | 0.003 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.940306e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.943220e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.943971e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.946736e-01 | 0.002 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.947921e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.952473e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.952473e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.956849e-01 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.957593e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.958010e-01 | 0.002 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.959024e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.962042e-01 | 0.002 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.962252e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.965623e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.966238e-01 | 0.001 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.966238e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.969707e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.972263e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.973122e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.978652e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.980222e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.983176e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.983232e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.983610e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.986339e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.986440e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.986440e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.988839e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.989293e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.990413e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.991808e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.992609e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.993161e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.993850e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.993850e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.993898e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.994074e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994586e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.995569e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.996015e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.996134e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.996352e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.996691e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.996782e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.996923e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.997255e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.997255e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997596e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.997943e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998051e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998262e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998617e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998766e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998766e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998878e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998899e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.998917e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998984e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999124e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999129e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999192e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999260e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999269e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999334e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999408e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999606e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999606e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999744e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.999792e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.999827e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999830e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999845e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999894e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999897e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999904e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999913e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999921e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999937e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999960e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999973e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999977e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999987e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999991e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999992e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999993e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by BMP | R-HSA-201451 | 1.000000e+00 | 0.000 | 1 | 1 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 1.000000e+00 | 0.000 | 1 | 1 |